<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6273821</article-id><article-id pub-id-type="doi">10.3390/molecules21091252</article-id><article-id pub-id-type="publisher-id">molecules-21-01252</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Gihyun</given-names></name><xref ref-type="aff" rid="af1-molecules-21-01252">1</xref><xref ref-type="aff" rid="af2-molecules-21-01252">2</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Sun Kwang</given-names></name><xref ref-type="aff" rid="af1-molecules-21-01252">1</xref><xref rid="c1-molecules-21-01252" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Trabace</surname><given-names>Luigia</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-21-01252"><label>1</label>Department of Physiology, College of Korean Medicine, Kyung Hee University, 26 Kyunghee-daero, Dongdaemoon-gu, Seoul 02447, Korea; <email>glee@khu.ac.kr</email></aff><aff id="af2-molecules-21-01252"><label>2</label>Department of Research and Development, National Development Institute of Korean Medicine, 94 Hwarang-ro, Gyeongsan-si, Gyeongsangbuk-do 38540, Korea</aff><author-notes><corresp id="c1-molecules-21-01252"><label>*</label>Correspondence: <email>skkim77@khu.ac.kr</email>; Tel.: +82-2-961-0491</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>9</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2016</year></pub-date><volume>21</volume><issue>9</issue><elocation-id>1252</elocation-id><history><date date-type="received"><day>11</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>12</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 by the authors.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent adverse effect of neurotoxic anticancer medicines. It leads to autonomic and somatic system dysfunction and decreases the patient&#x02019;s quality of life. This side effect eventually causes chemotherapy non-compliance. Patients are prompted to seek alternative treatment options since there is no conventional remedy for CIPN. A range of medicinal herbs have multifarious effects, and they have shown some evidence of efficacy in various neurological and immunological diseases. While CIPN has multiple mechanisms of neurotoxicity, these phytomedicines might offer neuronal protection or regeneration with the multiple targets in CIPN. Thus far, researchers have investigated the therapeutic benefits of several herbs, herbal formulas, and phytochemicals in preventing the onset and progress of CIPN in animals and humans. Here, we summarize current knowledge regarding the role of phytochemicals, herb extracts, and herbal formulas in alleviating CIPN.</p></abstract><kwd-group><kwd>phytochemical</kwd><kwd>medicinal herb</kwd><kwd>chemotherapy-induced peripheral neuropathy</kwd></kwd-group></article-meta></front><body><sec id="sec1-molecules-21-01252"><title>1. Introduction</title><p>Several antineoplastic medicines are reported to cause neurotoxicity and can develop chemotherapy-induced peripheral neuropathy (CIPN) [<xref rid="B1-molecules-21-01252" ref-type="bibr">1</xref>]. These drugs have effects on sensory nerves and cause substantial pain, dysfunction, and finally chemotherapy non-compliance [<xref rid="B2-molecules-21-01252" ref-type="bibr">2</xref>,<xref rid="B3-molecules-21-01252" ref-type="bibr">3</xref>]. This adverse effect damages peripheral nerves and can lead to sensory deficits, gait impairment [<xref rid="B4-molecules-21-01252" ref-type="bibr">4</xref>], or severe neuropathic pain [<xref rid="B5-molecules-21-01252" ref-type="bibr">5</xref>], and can severely degrade the patient&#x02019;s quality of life [<xref rid="B6-molecules-21-01252" ref-type="bibr">6</xref>]. The most common symptoms reported by patients include sensory symptoms such as numbness, burning, tingling, throbbing, and burning feelings. Moreover, patients may experience motor symptoms, such as dropping items, splaying fingers, and inability to complete normal daily activities [<xref rid="B7-molecules-21-01252" ref-type="bibr">7</xref>,<xref rid="B8-molecules-21-01252" ref-type="bibr">8</xref>]. </p><p>CIPN is difficult to prevent and control without dose-reduction or cessation of anticancer drugs [<xref rid="B9-molecules-21-01252" ref-type="bibr">9</xref>]. The overall incidence of this adverse effect is remarkably high [<xref rid="B10-molecules-21-01252" ref-type="bibr">10</xref>], although the population affected depends on chemotherapy drugs, dose, and exposure time [<xref rid="B11-molecules-21-01252" ref-type="bibr">11</xref>,<xref rid="B12-molecules-21-01252" ref-type="bibr">12</xref>]. Usually the symptoms of CIPN are reversible; however, sometimes symptoms are irreversible [<xref rid="B13-molecules-21-01252" ref-type="bibr">13</xref>] and worsen after withdrawal of drugs, including vincristine, cisplatin, oxaliplatin, or paclitaxel [<xref rid="B14-molecules-21-01252" ref-type="bibr">14</xref>,<xref rid="B15-molecules-21-01252" ref-type="bibr">15</xref>,<xref rid="B16-molecules-21-01252" ref-type="bibr">16</xref>].</p><p>Thus far, various pharmacological tactics have been attempted to attenuate CIPN symptoms. These medications include acetyl-<sc>l</sc>-carnitine, amifostine, glutathione, glutamine, vitamin E, PARP inhibitors, leukemia inhibitory factor, <italic>N</italic>-acetylcysteine, Ca/Mg, and venlafaxine [<xref rid="B17-molecules-21-01252" ref-type="bibr">17</xref>,<xref rid="B18-molecules-21-01252" ref-type="bibr">18</xref>,<xref rid="B19-molecules-21-01252" ref-type="bibr">19</xref>]. The therapeutic potentials of these drugs are limited by unexpected adverse effects and contradictory results, although these drugs have shown benefits in preventing CIPN [<xref rid="B20-molecules-21-01252" ref-type="bibr">20</xref>,<xref rid="B21-molecules-21-01252" ref-type="bibr">21</xref>]. Still, no approach has sufficient evidence for recommending use in CIPN treatment. Hence, alternative methods of preventing or treating CIPN are necessary.</p><p>Medicinal herbs have been used as therapeutics for centuries throughout the world. Phytochemicals derived from these medicinal plants are used to treat various neurological and immunological disorders. On the basis of recent literature, several phytochemicals, herbs, and herbal formulas exhibiting promising effects on CIPN have been identified. Here, we summarize the therapeutic effects of phytochemicals (see also <xref rid="molecules-21-01252-t001" ref-type="table">Table 1</xref>), medicinal herbs (<xref rid="molecules-21-01252-t002" ref-type="table">Table 2</xref>), and herbal formulas (<xref rid="molecules-21-01252-t003" ref-type="table">Table 3</xref>) against CIPN induced by vincristine, cisplatin, oxaliplatin, and paclitaxel. </p></sec><sec id="sec2-molecules-21-01252"><title>2. Phytochemicals and Medicinal Herbs against Vincristine-Induced Peripheral Neuropathy</title><p>Vincristine is one of the most extensively used chemotherapeutic agents to treat diverse types of cancer, including Hodgkin&#x02018;s disease, small cell lung cancer, acute myeloid leukemia, acute lymphocytic leukemia, and neuroblastoma. Vincristine inhibits chromosome separation during the metaphase resulting in cell apoptosis [<xref rid="B49-molecules-21-01252" ref-type="bibr">49</xref>]. Patients can experience some side effects from vincristine treatment, such as headaches, hair loss, walking difficulty, constipation, and a change in sensation. In serious cases, neuropathic pain, classically resulting in autonomic and peripheral sensory-motor neuropathy limits the dose of vincristine. Vincristine-induced peripheral neuropathy can worsen after therapy has ended [<xref rid="B50-molecules-21-01252" ref-type="bibr">50</xref>].</p><sec id="sec2dot1-molecules-21-01252"><title>2.1. Acorus calamus</title><p><italic>Acorus calamus</italic> is a medicinal herb used to alleviate pain or severe inflammation in Ayurveda. The root of the plant is widely used to treat a number of illnesses such as abdominal tumors, chronic diarrhea, dysentery, epilepsy, fever, mental ailments, kidney and liver issues, and rheumatism [<xref rid="B51-molecules-21-01252" ref-type="bibr">51</xref>]. Hydro-alcoholic extracts of <italic>A. calamus</italic> rhizoma (100&#x02013;200 mg/kg, p.o. for 14 consecutive days) protect against painful neuropathy induced by vincristine in rats. The extracts inhibit vincristine-induced biochemical (increase in superoxide anion generation level and total calcium level, and myeloperoxidase activity in the sciatic nerve) and behavioral (thermal- and mechano-hyperalgesia) changes to an extent comparable to Lyrica (pregabalin) [<xref rid="B28-molecules-21-01252" ref-type="bibr">28</xref>]. The ethanolic extract of <italic>A. calamus</italic> (up to 600 mg/kg) did not cause lethality and any changes in the general behavior in rats in both acute and chronic toxicity tests [<xref rid="B52-molecules-21-01252" ref-type="bibr">52</xref>].</p></sec><sec id="sec2dot2-molecules-21-01252"><title>2.2. Auraptenol</title><p>Auraptenol (8-(2-hydroxy-3-methylbut-3-enyl)-7-methoxychromen-2-one) is a phytochemical isolated from <italic>Angelicae dahuricae radix</italic>. The root of the plant is used to treat harmful exterior stimuli on the skin, such as dryness, dampness, heat, and cold in Oriental medicine [<xref rid="B53-molecules-21-01252" ref-type="bibr">53</xref>]. It has been shown that its antinociceptive effects are linked to the facilitated release of endogenous opioids [<xref rid="B54-molecules-21-01252" ref-type="bibr">54</xref>] and that a single oral administration of <italic>A.</italic>
<italic>dahuricae</italic> (3.25 g or 6.5 g) decreased cold-induced tonic pain in a dose-dependent manner in clinical trials [<xref rid="B55-molecules-21-01252" ref-type="bibr">55</xref>]. It reverted mechanical hyperalgesia induced by vincristine through 5-HT<sub>1A</sub> receptors in a dose-dependent manner (within the 0.05&#x02013;0.8 mg/kg range). The highest dose of auraptenol (0.8 mg/kg, i.p.) totally suppressed the mechanical hyperalgesia without affecting the general locomotor activity [<xref rid="B22-molecules-21-01252" ref-type="bibr">22</xref>].</p></sec><sec id="sec2dot3-molecules-21-01252"><title>2.3. Butea monosperma</title><p><italic>Butea monosperma</italic> is a medium-sized deciduous tree that has been used as an aphrodisiac, astringent, tonic, and diuretic in Ayurveda [<xref rid="B56-molecules-21-01252" ref-type="bibr">56</xref>]. The plant contains many phytocomponents, including saponins, glycosides, mucilage, gums, and fatty acids [<xref rid="B57-molecules-21-01252" ref-type="bibr">57</xref>]. Oral intake of ethanolic extract of <italic>B. monosperma</italic> (200&#x02013;400 mg/kg for 14 days) suppressed histological, biochemical, and behavioral changes induced by vincristine in rats. Authors have suggested that the therapeutic benefits might originate from its calcium channel inactivating, anti-oxidative, anti-inflammatory, and neuroprotective effects [<xref rid="B29-molecules-21-01252" ref-type="bibr">29</xref>].</p></sec><sec id="sec2dot4-molecules-21-01252"><title>2.4. Cannabinoids</title><p>Historically, <italic>Cannabis sativa</italic> has used to treat neuropathic pain. Cannabinoids repress neurotransmitter release in the brain by binding on cannabinoid receptors in cells [<xref rid="B58-molecules-21-01252" ref-type="bibr">58</xref>] and have anti-inflammatory effects [<xref rid="B59-molecules-21-01252" ref-type="bibr">59</xref>]. Rahn et al. investigated the effect of synthetic &#x00394;<sup>9</sup>-tetrahydrocannabinol analog on vincristine-induced mechanical allodynia in rats. The experiment demonstrated that cannabinoids can inhibit vincristine-induced mechanical allodynia through the cannabinoid receptor 1/2 pathway and the effect is mediated at the level of the spinal cord in part, although these synthetic cannabinoids may have some different pharmacological effects from phytocannabinoids [<xref rid="B60-molecules-21-01252" ref-type="bibr">60</xref>]. Cannabinoids have shown anti-cancer activities in animal models of cancer, and they are currently being tested as anti-tumor agents in phase I/II clinical trials [<xref rid="B61-molecules-21-01252" ref-type="bibr">61</xref>].</p></sec><sec id="sec2dot5-molecules-21-01252"><title>2.5. Ginkgo biloba L.</title><p><italic>Ginkgo</italic> leaf extract has been used for pharmaceutical purposes since 1965 and is one of the bestselling herbal medicines in the world [<xref rid="B62-molecules-21-01252" ref-type="bibr">62</xref>]. Park et al. showed that <italic>Ginkgo biloba</italic> extract (50&#x02013;150 mg/kg, p.o.) decreased the paw withdrawal frequency to cold stimuli and increased the withdrawal threshold to mechanical stimuli in peripheral neuropathy-induced rats [<xref rid="B30-molecules-21-01252" ref-type="bibr">30</xref>]. They suggested that the anti-hyperalgesic effect of <italic>G. biloba</italic> extract may be related to suppression of axonal degradation, improved axonal transport, and inhibition of TNF-&#x003b1; and NO production. The few recent studies on the anticancer activity of the extract in in vitro models showed the cell proliferation inhibition, tumor suppression, and DNA damage-repairing effects of the extract [<xref rid="B63-molecules-21-01252" ref-type="bibr">63</xref>,<xref rid="B64-molecules-21-01252" ref-type="bibr">64</xref>,<xref rid="B65-molecules-21-01252" ref-type="bibr">65</xref>]. Biggs et al. analyzed the risk of cancer hospitalization between participants assigned to <italic>Ginkgo</italic> extract treatment and those assigned to placebo and reported that the data do not support the regular use of <italic>G. biloba</italic> for reducing the risk of cancer [<xref rid="B66-molecules-21-01252" ref-type="bibr">66</xref>].</p></sec><sec id="sec2dot6-molecules-21-01252"><title>2.6. Ocimum sanctum L.</title><p>In traditional medicine, <italic>Ocimum sanctum</italic> L. has been recommended for the treatment of skin diseases, bronchitis, diarrhea, malaria, and arthritis. Recent research has also demonstrated its cardioprotective, anti-microbial, anti-fungal, anti-fertility, anti-diabetic, anti-cancer, and analgesic properties [<xref rid="B67-molecules-21-01252" ref-type="bibr">67</xref>]. Its leaf oil contains eugenol, eugenic acid, ursolic acid, carvacrol, linalool, limatrol, caryophyllene, and methyl carvacrol [<xref rid="B68-molecules-21-01252" ref-type="bibr">68</xref>]. Kaur et al. demonstrated that oral administration of <italic>O. sanctum</italic> or its saponin-rich fraction (100 and 200 mg/kg, for 14 days) reduced neurotoxicity induced by vincristine in rats with a decline in calcium levels and oxidative stress, thus helping to prevent CIPN symptoms. They estimated that the saponin-rich fraction may mediate the therapeutic effects of <italic>O. sanctum</italic> in neuropathic pain [<xref rid="B33-molecules-21-01252" ref-type="bibr">33</xref>]. Seed oil supplementation of <italic>O. sanctum</italic> L. (100 &#x003bc;L/kg) reduced 20-methaylcholathrene-induced tumor incidence and tumor volume and enhanced the survival rate in mice [<xref rid="B69-molecules-21-01252" ref-type="bibr">69</xref>].</p></sec><sec id="sec2dot7-molecules-21-01252"><title>2.7. Xylopic Acid</title><p>Traditionally, the fruit of <italic>Xylopia aethiopica</italic> has been used to manage pain disorders, including neuralgia and headache [<xref rid="B70-molecules-21-01252" ref-type="bibr">70</xref>]. Ethanolic extract of <italic>X. aethiopica</italic> (30&#x02013;300 mg/kg, p.o.) and its major diterpene xylopic acid (15-(acetyloxy)kaur-16-en-18-oic acid; 10&#x02013;100 mg/kg, p.o.) exhibit anti-allodynic and anti-hyperalgesic properties in vincristine-induced neuropathic pain. Diterpene xylopic acid from <italic>X. aethiopica</italic> exhibited greater potency than the ethanolic extract of <italic>X. aethiopica</italic> itself, while pregabalin (10&#x02013;100 mg/kg) showed a comparable effect to xylopic acid [<xref rid="B27-molecules-21-01252" ref-type="bibr">27</xref>]. Treatment with <italic>X. aethiopica</italic> extract led to a dose-dependent growth inhibition in many cell lines, including HCT116 colon cancer cells, U937, and KG1a leukemia cells, and the C-33A cervical cancer cell line [<xref rid="B71-molecules-21-01252" ref-type="bibr">71</xref>,<xref rid="B72-molecules-21-01252" ref-type="bibr">72</xref>], but xylopic acid, unlike kaurenoic acid, has no cytotoxic effects on human cancer cells [<xref rid="B73-molecules-21-01252" ref-type="bibr">73</xref>].</p></sec></sec><sec id="sec3-molecules-21-01252"><title>3. Phytochemicals and Medicinal Herbs against Cisplatin-Induced Peripheral Neuropathy</title><p>Cisplatin is the first member of platinum-based antineoplastic medicine. This platinum complex causes the crosslinking of two DNA strands in cells, which prevents cell division and finally leads to programmed cell death. In addition to nephrotoxicity, neurotoxicity and ototoxicity are dose-limiting adverse effects of cisplatin treatment [<xref rid="B74-molecules-21-01252" ref-type="bibr">74</xref>,<xref rid="B75-molecules-21-01252" ref-type="bibr">75</xref>].</p><sec id="sec3dot1-molecules-21-01252"><title>3.1. Curcumin</title><p>Curcumin ((1<italic>E</italic>,6<italic>E</italic>)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is a yellow pigment component of <italic>Curcuma longa</italic>. This phytochemical is well known for its powerful anti-inflammatory and antioxidant properties. It has demonstrated benefits in neuronal diseases such as alcoholic neuropathy and diabetic neuropathy [<xref rid="B76-molecules-21-01252" ref-type="bibr">76</xref>,<xref rid="B77-molecules-21-01252" ref-type="bibr">77</xref>,<xref rid="B78-molecules-21-01252" ref-type="bibr">78</xref>]. In the cisplatin-treated model, curcumin (10 mg/kg, oral) reversed the neurotensin changes in the plasma, reduced cisplatin absorption in the sciatic nerve, and notably ameliorated sciatic nerve histology [<xref rid="B24-molecules-21-01252" ref-type="bibr">24</xref>]. Curcumin regulates the growth of cancer cells by the modulation of multiple cell signaling pathways, including protein kinase, mitochondrial, death receptor, caspase activation, cell survival, tumor suppressor, and cell proliferation pathways [<xref rid="B79-molecules-21-01252" ref-type="bibr">79</xref>]. Extensive in vivo data support curcumin&#x02019;s beneficial effects against cancer [<xref rid="B80-molecules-21-01252" ref-type="bibr">80</xref>,<xref rid="B81-molecules-21-01252" ref-type="bibr">81</xref>,<xref rid="B82-molecules-21-01252" ref-type="bibr">82</xref>]; however, there are also conflicting reports that curcumin can promote cancer in mice [<xref rid="B83-molecules-21-01252" ref-type="bibr">83</xref>,<xref rid="B84-molecules-21-01252" ref-type="bibr">84</xref>].</p></sec><sec id="sec3dot2-molecules-21-01252"><title>3.2. Ginkgo biloba L.</title><p>Ozturk et al. showed that oral administration of <italic>G. biloba</italic> alcoholic extract is beneficial in preventing peripheral neuropathy induced by cisplatin in mice. In their experiments, <italic>G. biloba</italic> extract reduced cisplatin-induced immigrated cell numbers, sensory nerve conduction velocity, and outgrowing of axons [<xref rid="B31-molecules-21-01252" ref-type="bibr">31</xref>].</p></sec><sec id="sec3dot3-molecules-21-01252"><title>3.3. Salvia officinalis</title><p><italic>Salvia officinalis</italic> (Sage) is a perennial herb with well-known carminative, antispasmodic, antiseptic, astringent, and antihydrotic properties [<xref rid="B85-molecules-21-01252" ref-type="bibr">85</xref>]. The phytocomplexes of <italic>S. officinalis</italic> contain monoterpenes with a broad range of carbon skeletons, including acyclic, monocyclic, and bicyclic compounds, phenolic compounds, diterpenes, triterpenes [<xref rid="B86-molecules-21-01252" ref-type="bibr">86</xref>,<xref rid="B87-molecules-21-01252" ref-type="bibr">87</xref>]. An alcoholic extract of <italic>S. officinalis</italic> leaf (100 mg/kg i.p.) exhibited an anti-nociceptive effect on cisplatin-induced hyperalgesia in mice. In the formalin test, the aqueous extract effectively suppressed the second phase of pain. The extract even showed stronger benefits than morphine [<xref rid="B34-molecules-21-01252" ref-type="bibr">34</xref>]. Vujosevic et al. showed anti-mutagenic effects of <italic>S. officinalis</italic> in a mammalian system in vivo [<xref rid="B88-molecules-21-01252" ref-type="bibr">88</xref>], and Keshavarz et al. showed its anti-angiogenic properties for anti-tumor effect in chicken eggs [<xref rid="B89-molecules-21-01252" ref-type="bibr">89</xref>].</p></sec><sec id="sec3dot4-molecules-21-01252"><title>3.4. Walnut</title><p>Walnut is one of the traditional anti-tumor, anti-inflammatory, blood purifying, and antioxidant agents. Shabani et al. investigated whether walnut has a neuroprotective property on neurotoxicity induced by cisplatin. Dietary walnut (6%) altered cerebellum- and hippocampus- related behaviors caused by continuous cisplatin injection in male rats. Dietary walnut also ameliorated motor and memory capacities in cisplatin-treated rats. Cisplatin increased, but walnut decreased the latency to nociceptive stimuli [<xref rid="B35-molecules-21-01252" ref-type="bibr">35</xref>]. Dietary walnut suppressed mammary gland tumorigenesis in the C(3)1 TAg mouse [<xref rid="B90-molecules-21-01252" ref-type="bibr">90</xref>] and growth of implanted MDA-MB 231 human breast cancer cells in nude mice [<xref rid="B91-molecules-21-01252" ref-type="bibr">91</xref>]. It has also been demonstrated that walnut reduces growth of prostate cancer [<xref rid="B92-molecules-21-01252" ref-type="bibr">92</xref>,<xref rid="B93-molecules-21-01252" ref-type="bibr">93</xref>] and colorectal cancer [<xref rid="B94-molecules-21-01252" ref-type="bibr">94</xref>].</p></sec></sec><sec id="sec4-molecules-21-01252"><title>4. Phytochemicals and Medicinal Herbs against Oxaliplatin-Induced Peripheral Neuropathy</title><p>Oxaliplatin is a platinum-based anti-neoplastic agent used for treating advanced colorectal cancer [<xref rid="B95-molecules-21-01252" ref-type="bibr">95</xref>]. Its cytotoxicity is considered to result from the inhibition of DNA synthesis, similar to that of other platinum complexes. Oxaliplatin forms both intra- and inter-strand crosslinks in DNA, which prevent DNA transcription and replication, resulting in programmed cell death [<xref rid="B96-molecules-21-01252" ref-type="bibr">96</xref>]. This chemotherapeutic drug is typically used alongside a combination of folinic acid and 5-fluorouracil (FOLFOX). Oxaliplatin has less ototoxicity and nephrotoxicity than cisplatin; however, oxaliplatin treatment can still cause neurotoxicity and ototoxicity [<xref rid="B97-molecules-21-01252" ref-type="bibr">97</xref>].</p><sec id="sec4dot1-molecules-21-01252"><title>4.1. Curcumin</title><p>Al Moundhri et al. showed that oral administration of curcumin (10 mg/kg) reduced drug consistency in the sciatic nerve and prominently ameliorated sciatic nerve injury in oxaliplatin-induced neurotoxicity in rats [<xref rid="B24-molecules-21-01252" ref-type="bibr">24</xref>]. Wassem and Parvez showed that curcumin can ameliorate changes in both enzymatic and nonenzymatic antioxidants of mitochondria in vitro. The results reveal the potential of curcumin as a substance that can diminish oxaliplatin-induced peripheral neurotoxicity [<xref rid="B98-molecules-21-01252" ref-type="bibr">98</xref>].</p></sec><sec id="sec4dot2-molecules-21-01252"><title>4.2. Rutin and Quercetin</title><p>Rutin (2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2<italic>S</italic>,3<italic>R</italic>,4<italic>S</italic>,5<italic>S</italic>,6<italic>R</italic>)-3,4,5-trihydroxy-6-({[(2<italic>R</italic>,3<italic>R</italic>,4<italic>R</italic>,5<italic>R</italic>,6<italic>S</italic>)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4<italic>H</italic>-chromen-4-one) and quercetin (2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4<italic>H</italic>-chromen-4-one) are polyphenolic flavonoids found in many medicinal herbs and vegetables. They have been reported to have powerful antioxidant, anti-inflammatory, and anti-nociceptive activities. Rutin is water-soluble and is converted to quercetin once it enters the bloodstream [<xref rid="B99-molecules-21-01252" ref-type="bibr">99</xref>]. In alcohol-induced neuropathy, quercetin compound showed remarkable anti-nociceptive and neuroprotective effects [<xref rid="B100-molecules-21-01252" ref-type="bibr">100</xref>]. In oxaliplatin-treated rats, rutin and quercetin (25, 50, and 100 mg/kg, i.p.) suppressed neuronal contraction and averted development of edema. Moreover, c-Fos, a marker of neuroplasticity, was decreased by rutin- or quercetin- pretreatment [<xref rid="B25-molecules-21-01252" ref-type="bibr">25</xref>]. The neuroprotective mechanism of these phytochemicals is connected to its amelioration of mitochondrial dysfunction [<xref rid="B98-molecules-21-01252" ref-type="bibr">98</xref>]. Interestingly, quercetin, but not rutin, inhibited azoxymethane-induced colorectal carcinogenesis in rats [<xref rid="B101-molecules-21-01252" ref-type="bibr">101</xref>]. Quercetin has been used in clinical trials in cancer patients. The results demonstrated that quercetin can be safely administered by i.v. and that its anticancer properties are detectable [<xref rid="B102-molecules-21-01252" ref-type="bibr">102</xref>].</p></sec><sec id="sec4dot3-molecules-21-01252"><title>4.3. Camellia sinensis (Green Tea)</title><p><italic>Camellia sinensis</italic> is a small tree in which the leaves are used to produce green tea, a popular beverage with therapeutic applications. The key bioactive substances of <italic>C. sinensis</italic> are catechins. A range of studies have demonstrated that these substances have strong anti-inflammatory, antioxidant, and anticancer properties [<xref rid="B103-molecules-21-01252" ref-type="bibr">103</xref>]. The therapeutic property of <italic>C. sinensis</italic> was tested against oxaliplatin-induced peripheral neuropathy. Oral administration of green tea extract (300 mg/kg for 6 weeks) forcefully attenuated thermal hyperalgesia and mechanical allodynia; however, it did not avert morphometric or electrophysiological changes [<xref rid="B32-molecules-21-01252" ref-type="bibr">32</xref>]. The experimental evidence exhibiting the cancer-preventive activity of green tea is increasing rapidly [<xref rid="B104-molecules-21-01252" ref-type="bibr">104</xref>]. Nakachi et al. suggested that consumption of green tea prior to cancer development was markedly associated with improved prognosis of stage I/II breast cancer [<xref rid="B105-molecules-21-01252" ref-type="bibr">105</xref>].</p></sec><sec id="sec4dot4-molecules-21-01252"><title>4.4. Gyeryongtongrac-Bang (Guilongtongluofang in Chinese)</title><p>Gyeryongtongrac-Bang is a traditional medicine used to relieve numbness and cold sensation in patients. One hundred twenty colorectal cancer patients who were treated with oxaliplatin were randomly assigned to the Gyeryongtongrac-Bang-treated group (which received aqueous extract from <italic>Ramulus cinnamomi</italic>, <italic>Earthworm</italic>, <italic>Radix astragali</italic>, <italic>Safflower</italic>, <italic>Radix</italic>
<italic>angelicae sinensis</italic>, <italic>Ligusticum</italic>, <italic>Spatholobus</italic>, <italic>Radix paeoniae alba</italic>, <italic>Rhizoma curcumae</italic>, and <italic>Licorice</italic> once a day) and the control group (which received placebo) in a double-blind trial. A total of 51.7% patients in the Gyeryongtongrac-Bang-treated group showed neurotoxicity, whereas, it was seen in 70.0% of the placebo-treated group after 4 cycles of treatment. The results suggest that Gyeryongtongrac-Bang can be a potent agent that prevents neurotoxic pain without diminishing oxaliplatin-attributed benefits. Additionally, the development of sensory neurotoxicity was delayed in the Gyeryongtongrac-Bang-treated group [<xref rid="B37-molecules-21-01252" ref-type="bibr">37</xref>].</p></sec><sec id="sec4dot5-molecules-21-01252"><title>4.5. Gyejigachulbu-Tang (Keishikajutsubuto in Japanese)</title><p>Gyejigachulbu-Tang is an herbal formula including <italic>Aconiti tuber</italic>, <italic>Atractylodis lanceae rhizome</italic>, <italic>Cinnamomi cortex</italic>, <italic>Glycyrrhizae radix</italic>, <italic>Paeoniae radix</italic>, <italic>Zingiberis rhizoma</italic>, and <italic>Zizyphi fructus</italic>. In our experiment, oral administration of Gyejigachulbu-Tang (200, 400, and 600 mg/kg for 5 days) markedly ameliorated mechanical- and cold-allodynia induced by oxaliplatin treatment. The formula possibly functions through the suppression of spinal glial activation [<xref rid="B36-molecules-21-01252" ref-type="bibr">36</xref>]. We confirmed that the extract of <italic>Aconiti tuber</italic> could attenuate both cold and mechanical allodynia similar to Gyejigachulbu-Tang treatment. Interestingly, <italic>Cinnamomi cortex</italic> and coumarin, a phytochemical from <italic>C. cortex</italic>, also attenuated cold allodynia induced by oxaliplatin treatment in rats (unpublished data). These results suggest that both <italic>A. tuber</italic> and <italic>C. cortex</italic> have neuroprotective properties against oxaliplatin-induced neuropathy, thereby playing a major role in the anti-allodynic effect of Gyejigachulbu-Tang.</p></sec><sec id="sec4dot6-molecules-21-01252"><title>4.6. Jesengsingi-Hwan (Goshajinkigan in Japanese)</title><p>Jesengsingi-Hwan is a traditional herbal formula widely used in Asia. It contains 10 different herbs comprising <italic>Achyranthis bidentatae radix</italic>, <italic>Alismatis rhizome</italic>, <italic>A. tuber</italic>, <italic>C. cortex</italic>, <italic>Corni fructus</italic>, <italic>Dioscorea opposita rhizoma</italic>, <italic>Plantaginis semen</italic>, <italic>Poria alba</italic>, <italic>Moutan cortex</italic>, and <italic>Rehmannia viride radix</italic>. Recently, the beneficial properties of Jesengsingi-Hwan on CIPN have been widely prospected. In a murine study, Ushino et al. showed that Jesengsingi-Hwan can reduce CIPN without influence on anti-cancer potency [<xref rid="B41-molecules-21-01252" ref-type="bibr">41</xref>]. Kono et al. examined a preventive effect of Jesengsingi-Hwan on chronic oxaliplatin-induced hypoesthesia in rats. Oral administration of Jesengsingi-Hwan (0.3 or 1.0 g/kg, 5 times a week for 8 weeks) ameliorated abnormal sensations and histological damage to the sciatic nerve [<xref rid="B42-molecules-21-01252" ref-type="bibr">42</xref>]. In a retrospective clinical study, Kono et al. examined the benefits of Jesengsingi-Hwan on oxaliplatin treatment involved in peripheral neuropathy. In the study, the administration of Jesengsingi-Hwan (7.5 g/day) reduced the neurotoxicity of oxaliplatin in colorectal cancer patients [<xref rid="B44-molecules-21-01252" ref-type="bibr">44</xref>]. Later, they again reported that daily oral administration of Jesengsingi-Hwan (7.5 g/day) has the capability to delay the development of grade 2 or greater oxaliplatin-induced peripheral neurotoxicity without impairing FOLFOX efficacy in a randomized phase II study [<xref rid="B45-molecules-21-01252" ref-type="bibr">45</xref>]. Yoshida et al. also assessed the effects of Jesengsingi-Hwan for oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients. Twenty-nine colorectal cancer patients received &#x02265;4 weeks of Jesengsingi-Hwan (2.5 g orally 3 times daily before or between meals for a total of 7.5&#x02009; g/day) for oxaliplatin-induced peripheral neuropathy during chemotherapy. They were compared to 44 patients who had not received Jesengsingi-Hwan during the same period. A Kaplan-Meier analysis showed that Jesengsingi-Hwan could prevent exacerbation of oxaliplatin-induced peripheral neuropathy [<xref rid="B46-molecules-21-01252" ref-type="bibr">46</xref>]. Hosokawa et al. assessed the preventive properties of Jesengsingi-Hwan on oxaliplatin-induced neurotoxicity in colorectal cancer patients and found that in the Jesengsingi-Hwan-treated group, 50% of oxaliplatin-induced peripheral neuropathy was prevented without diminishing chemotherapy efficacy [<xref rid="B47-molecules-21-01252" ref-type="bibr">47</xref>].</p></sec><sec id="sec4dot7-molecules-21-01252"><title>4.7. Hwanggiomul-Tang (Ogikeishigomotsuto in Japanese)</title><p>In Japan, a single case study was reported using Hwanggiomul-Tang for oxaliplatin-induced neuropathic pain. Hwanggiomul-Tang is an herbal mixture containing <italic>Zingiberis hizome</italic>, <italic>Jujubae fructus</italic>, <italic>Paeonia alba radix</italic>, <italic>C. cortex</italic>, and <italic>Astragalus membranaceus radix</italic>. The case study of a 59-year old man with recurrent colon cancer suggests that this herbal formula may be useful to reduce or prevent chronic cumulative neurotoxicity due to oxaliplatin [<xref rid="B38-molecules-21-01252" ref-type="bibr">38</xref>].</p></sec></sec><sec id="sec5-molecules-21-01252"><title>5. Phytochemicals and Medicinal Herbs against Paclitaxel-Induced Peripheral Neuropathy</title><p>Paclitaxel is a member of the taxane family of drugs used to treat ovarian, breast, lung, esophageal, prostate, bladder, and pancreatic cancer as well as Kaposi's sarcoma and melanoma [<xref rid="B106-molecules-21-01252" ref-type="bibr">106</xref>]. This tubulin-targeting drug protects the microtubule polymer from disassembly by stabilizing it. The stabilization triggers apoptosis through inhibition of mitosis [<xref rid="B107-molecules-21-01252" ref-type="bibr">107</xref>]. Paclitaxel-treated cells thus have defects in cell division, chromosome segregation, and mitotic spindle assembly. Paclitaxel can induce phenomena of sensory peripheral neuropathy, such as paresthesia and numbness in the extremities [<xref rid="B108-molecules-21-01252" ref-type="bibr">108</xref>]. Symmetrical loss of sensation is also a frequent occurrence. These neuropathy symptoms limit the use of paclitaxel.</p><sec id="sec5dot1-molecules-21-01252"><title>5.1. Cannabidiol</title><p>Cannabidiol (2-[(1<italic>R</italic>,6<italic>R</italic>)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol) is a key phytochemical accounting for approximately 40% of the <italic>C. sativa</italic> extract [<xref rid="B109-molecules-21-01252" ref-type="bibr">109</xref>]. This phytocannabinoid is known to have various medical applications on the basis of clinical reports showing the lack of side effects and particularly a lack of psychoactivity with anti-nausea, anti-psychotic, anti-anxiety, and anti-convulsive properties [<xref rid="B110-molecules-21-01252" ref-type="bibr">110</xref>]. Cannabidiol (2.5&#x02013;10 mg/kg, i.p. for 6 days) inhibited paclitaxel-induced neuropathic pain through 5-HT<sub>1A</sub> receptor signaling without diminishing chemotherapy efficacy or nervous system function in mice [<xref rid="B23-molecules-21-01252" ref-type="bibr">23</xref>].</p></sec><sec id="sec5dot2-molecules-21-01252"><title>5.2. Verticinone</title><p>Verticinone ((3&#x003b2;,5&#x003b1;)-3,20-dihydroxycevan-6-one) is a kind of isosteroidal alkaloid derived from <italic>Fritillaria bulbus</italic>. Xu et al. [<xref rid="B26-molecules-21-01252" ref-type="bibr">26</xref>] examined its analgesic effects using neuropathic pain and inflammation models in rats. The experiments showed that hydro-alcoholic extracted verticinone (1.5&#x02013;3 mg/kg, p.o.) has a relatively constant analgesic effect in paclitaxel-induced neuropathy; further, the analgesic effect of morphine was decreased after repeated medication. Authors believe verticinone is an anodyne with low tolerance.</p></sec><sec id="sec5dot3-molecules-21-01252"><title>5.3. Jesengshingi-Hwan</title><p>Bahar et al. reported that paclitaxel-induced allodynia was markedly prevented by Jesengshingi-Hwan (1 g/kg, p.o. daily) in mice, although Jesengshingi-Hwan could not suppress cancer-induced allodynia [<xref rid="B43-molecules-21-01252" ref-type="bibr">43</xref>]. Andoh et al. [<xref rid="B111-molecules-21-01252" ref-type="bibr">111</xref>] also reported that Jesengsingi-Hwan (0.1&#x02013;1.0 g/kg, p.o.) markedly inhibited paclitaxel-induced mechanical allodynia in mice. Authors predicted that <italic>Achyranthis radix</italic> and <italic>P. semen</italic> in Jesengsingi-Hwan may block the aggravation of paclitaxel-induced neuropathic pain. Yamamoto et al. reported that Jesengsingi-Hwan treatment was beneficial for the treatment of paclitaxel-induced neuropathic pain in eighty-two patients enrolled in clinical trials. The investigators believe its preventive effect may be more potent if it is administered from the start of chemotherapy for breast, colorectal, or gynecological cancer patients [<xref rid="B48-molecules-21-01252" ref-type="bibr">48</xref>].</p></sec><sec id="sec5dot4-molecules-21-01252"><title>5.4. Jakyakgamcho-Tang (Shakuyakukanzoto in Japanese)</title><p>Jakyakgamcho-Tang is an herbal mixture of <italic>Paeoniae radix</italic> and <italic>Glycyrrhizae radix</italic>. A mouse study found that this combination (1.75 mg/mouse) remarkably attenuated paclitaxel-induced hyperalgesia and allodynia [<xref rid="B39-molecules-21-01252" ref-type="bibr">39</xref>]. Through retrospective case analysis on 23 ovarian cancer patients, Fujii et al. [<xref rid="B40-molecules-21-01252" ref-type="bibr">40</xref>] concluded that Jakyakgamcho-Tang (7.5 g/day, p.o. for 8 days) has a remedial value in neuropathic pain after paclitaxel and carboplatin combination chemotherapy. Authors suggest that paclitaxel combination chemotherapy with Jakyakgamcho-Tang taken orally is a safer and more tolerable way to reduce pain in epithelial ovarian carcinoma.</p></sec></sec><sec id="sec6-molecules-21-01252"><title>6. Conclusions and Perspectives</title><p>Despite the high incidence of CIPN and its dose-limiting effects, there are no current treatments or preventive options for CIPN with conclusive efficacy and safety data. The lack of effective therapeutic methods for CIPN has boosted the need for the use of medicinal herbs and phytochemicals; these have gained increasing attention as a major form of alternative therapy because they are convenient, economical, effective, safe, and therapeutic. Most recently, a number of phytochemicals and herbal medicines have shown potential for protective benefits for CIPN. Owing to the diverse mechanisms of CIPN, the results of phytotherapy using phytochemicals or herbs contributing to the multiple targets of CIPN seem to be encouraging.</p><p>To date, however, many of the therapeutic mechanisms of these phytotherapies remain unclear. For example, significant roles of transient receptor potential (TRP) channels for CIPN development have been discovered, but the link between phytotherapy and TRP channels is mostly unknown. An increasing number of studies report the involvement of TRP channels including TRPA1, TRPM8, TRPV1, and TRPV4 in CIPN [<xref rid="B112-molecules-21-01252" ref-type="bibr">112</xref>,<xref rid="B113-molecules-21-01252" ref-type="bibr">113</xref>,<xref rid="B114-molecules-21-01252" ref-type="bibr">114</xref>,<xref rid="B115-molecules-21-01252" ref-type="bibr">115</xref>]. Recent studies found that Jesengsingi-Hwan prevents oxaliplatin-induced peripheral neuropathy through the functional alteration in TRPA1 and TRPM8 [<xref rid="B116-molecules-21-01252" ref-type="bibr">116</xref>] and can reduce paclitaxel-induced peripheral neuropathy by suppressing TRPV4 expression [<xref rid="B117-molecules-21-01252" ref-type="bibr">117</xref>]. Moreover, the TRPV1-mediated anti-cancer effects of cannabidiol have been reported in multiple cancer cell lines, including breast [<xref rid="B118-molecules-21-01252" ref-type="bibr">118</xref>], lung [<xref rid="B119-molecules-21-01252" ref-type="bibr">119</xref>,<xref rid="B120-molecules-21-01252" ref-type="bibr">120</xref>], and colon [<xref rid="B121-molecules-21-01252" ref-type="bibr">121</xref>]. Inflammatory and neuro-immune responses also play important roles in the development and progression of CIPN [<xref rid="B122-molecules-21-01252" ref-type="bibr">122</xref>]. Phytotherapies, especially cannabinoids, have significant anti-inflammatory and immunomodulatory properties [<xref rid="B123-molecules-21-01252" ref-type="bibr">123</xref>]. More studies are necessary to further our understanding of the involved mechanisms such as TRP channels and immunomodulation. In addition, the dose of several phytochemicals and medicinal herbs for the treatment of animals appears high. At high doses, some of them can induce toxicity in the liver or kidneys. Thus, the dose should be interpreted and verified for toxicity. It is essential to find the maximum dose of phytochemicals and herbs for use in humans.</p><p>In conclusion, because of their multitarget, multilevel, and integrated benefits, medicinal herbs seem to be a feasible method for the management of CIPN. Phytochemicals, medicinal herbs, and their formulas could be considered for the treatment of CIPN. However, their curative usability should be examined in well-designed clinical trials. In addition, their reciprocal effects with other drugs in humans should be examined in detail.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by a grant of the Korea Health Technology R &#x00026; D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health &#x00026; Welfare, Republic of Korea (grant number: HI14C0738).</p></ack><notes><title>Author Contributions</title><p>G. Lee and S.K. Kim conceived and designed the study. G. Lee wrote the manuscript. Both authors revised and approved this manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-21-01252"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miltenburg</surname><given-names>N.C.</given-names></name><name><surname>Boogerd</surname><given-names>W.</given-names></name></person-group>
<article-title>Chemotherapy-induced neuropathy: A comprehensive survey</article-title>
<source>Cancer Treat. Rev.</source>
<year>2014</year>
<volume>40</volume>
<fpage>872</fpage>
<lpage>882</lpage>
<pub-id pub-id-type="doi">10.1016/j.ctrv.2014.04.004</pub-id>
<?supplied-pmid 24830939?><pub-id pub-id-type="pmid">24830939</pub-id></element-citation></ref><ref id="B2-molecules-21-01252"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jaggi</surname><given-names>A.S.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name></person-group>
<article-title>Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy</article-title>
<source>Toxicology</source>
<year>2012</year>
<volume>291</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.tox.2011.10.019</pub-id>
<?supplied-pmid 22079234?><pub-id pub-id-type="pmid">22079234</pub-id></element-citation></ref><ref id="B3-molecules-21-01252"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Egan</surname><given-names>M.</given-names></name><name><surname>Burke</surname><given-names>E.</given-names></name><name><surname>Meskell</surname><given-names>P.</given-names></name><name><surname>MacNeela</surname><given-names>P.</given-names></name><name><surname>Dowling</surname><given-names>M.</given-names></name></person-group>
<article-title>Quality of life and resilience related to chemotherapy-induced peripheral neuropathy in patients post treatment with platinums and taxanes</article-title>
<source>J. Res. Nurs.</source>
<year>2015</year>
<volume>20</volume>
<fpage>385</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1177/1744987115574296</pub-id>
</element-citation></ref><ref id="B4-molecules-21-01252"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Visovsky</surname><given-names>C.</given-names></name><name><surname>Collins</surname><given-names>M.</given-names></name><name><surname>Abbott</surname><given-names>L.</given-names></name><name><surname>Aschenbrenner</surname><given-names>J.</given-names></name><name><surname>Hart</surname><given-names>C.</given-names></name></person-group>
<article-title>Putting evidence into practice: Evidence-based interventions for chemotherapy-induced peripheral neuropathy</article-title>
<source>Clin. J. Oncol. Nurs.</source>
<year>2007</year>
<volume>11</volume>
<fpage>901</fpage>
<lpage>913</lpage>
<pub-id pub-id-type="doi">10.1188/07.CJON.901-913</pub-id>
<?supplied-pmid 18063548?><pub-id pub-id-type="pmid">18063548</pub-id></element-citation></ref><ref id="B5-molecules-21-01252"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cavaletti</surname><given-names>G.</given-names></name></person-group>
<article-title>Chemotherapy-induced peripheral neurotoxicity (cipn): What we need and what we know</article-title>
<source>J. Peripher. Nerv. Syst.</source>
<year>2014</year>
<volume>19</volume>
<fpage>66</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1111/jns5.12073</pub-id>
<?supplied-pmid 24976572?><pub-id pub-id-type="pmid">24976572</pub-id></element-citation></ref><ref id="B6-molecules-21-01252"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beijers</surname><given-names>A.J.</given-names></name><name><surname>Vreugdenhil</surname><given-names>G.</given-names></name><name><surname>Oerlemans</surname><given-names>S.</given-names></name><name><surname>Eurelings</surname><given-names>M.</given-names></name><name><surname>Minnema</surname><given-names>M.C.</given-names></name><name><surname>Eeltink</surname><given-names>C.M.</given-names></name><name><surname>van de Poll-Franse</surname><given-names>L.V.</given-names></name><name><surname>Mols</surname><given-names>F.</given-names></name></person-group>
<article-title>Chemotherapy-induced neuropathy in multiple myeloma: Influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice</article-title>
<source>Support. Care Cancer</source>
<year>2016</year>
<volume>24</volume>
<fpage>2411</fpage>
<lpage>2420</lpage>
<pub-id pub-id-type="doi">10.1007/s00520-015-3032-y</pub-id>
<?supplied-pmid 26634561?><pub-id pub-id-type="pmid">26634561</pub-id></element-citation></ref><ref id="B7-molecules-21-01252"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>S.B.</given-names></name><name><surname>Goldstein</surname><given-names>D.</given-names></name><name><surname>Krishnan</surname><given-names>A.V.</given-names></name><name><surname>Lin</surname><given-names>C.S.</given-names></name><name><surname>Friedlander</surname><given-names>M.L.</given-names></name><name><surname>Cassidy</surname><given-names>J.</given-names></name><name><surname>Koltzenburg</surname><given-names>M.</given-names></name><name><surname>Kiernan</surname><given-names>M.C.</given-names></name></person-group>
<article-title>Chemotherapy-induced peripheral neurotoxicity: A critical analysis</article-title>
<source>CA A Cancer J. Clin.</source>
<year>2013</year>
<volume>63</volume>
<fpage>419</fpage>
<lpage>437</lpage>
<pub-id pub-id-type="doi">10.3322/caac.21204</pub-id>
<?supplied-pmid 24590861?><pub-id pub-id-type="pmid">24590861</pub-id></element-citation></ref><ref id="B8-molecules-21-01252"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Argyriou</surname><given-names>A.A.</given-names></name><name><surname>Kyritsis</surname><given-names>A.P.</given-names></name><name><surname>Makatsoris</surname><given-names>T.</given-names></name><name><surname>Kalofonos</surname><given-names>H.P.</given-names></name></person-group>
<article-title>Chemotherapy-induced peripheral neuropathy in adults: A comprehensive update of the literature</article-title>
<source>Cancer Manag. Res.</source>
<year>2014</year>
<volume>6</volume>
<fpage>135</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.2147/CMAR.S44261</pub-id>
<?supplied-pmid 24672257?><pub-id pub-id-type="pmid">24672257</pub-id></element-citation></ref><ref id="B9-molecules-21-01252"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smith</surname><given-names>J.A.</given-names></name><name><surname>Benbow</surname><given-names>S.J.</given-names></name></person-group>
<article-title>Meeting report: Inaugural chemotherapy-induced peripheral neuropathy symposium&#x02014;Santa Barbara, CA, February 2015</article-title>
<source>Cancer Res.</source>
<year>2015</year>
<volume>75</volume>
<fpage>3696</fpage>
<lpage>3698</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-1145</pub-id>
<?supplied-pmid 26081810?><pub-id pub-id-type="pmid">26081810</pub-id></element-citation></ref><ref id="B10-molecules-21-01252"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cavaletti</surname><given-names>G.</given-names></name><name><surname>Zanna</surname><given-names>C.</given-names></name></person-group>
<article-title>Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity</article-title>
<source>Eur. J. Cancer</source>
<year>2002</year>
<volume>38</volume>
<fpage>1832</fpage>
<lpage>1837</lpage>
<pub-id pub-id-type="doi">10.1016/S0959-8049(02)00229-0</pub-id>
<pub-id pub-id-type="pmid">12204664</pub-id></element-citation></ref><ref id="B11-molecules-21-01252"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cavaletti</surname><given-names>G.</given-names></name><name><surname>Frigeni</surname><given-names>B.</given-names></name><name><surname>Lanzani</surname><given-names>F.</given-names></name><name><surname>Mattavelli</surname><given-names>L.</given-names></name><name><surname>Susani</surname><given-names>E.</given-names></name><name><surname>Alberti</surname><given-names>P.</given-names></name><name><surname>Cortinovis</surname><given-names>D.</given-names></name><name><surname>Bidoli</surname><given-names>P.</given-names></name></person-group>
<article-title>Chemotherapy-induced peripheral neurotoxicity assessment: A critical revision of the currently available tools</article-title>
<source>Eur. J. Cancer</source>
<year>2010</year>
<volume>46</volume>
<fpage>479</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejca.2009.12.008</pub-id>
<?supplied-pmid 20045310?><pub-id pub-id-type="pmid">20045310</pub-id></element-citation></ref><ref id="B12-molecules-21-01252"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cavaletti</surname><given-names>G.</given-names></name><name><surname>Cornblath</surname><given-names>D.R.</given-names></name><name><surname>Merkies</surname><given-names>I.S.</given-names></name><name><surname>Postma</surname><given-names>T.J.</given-names></name><name><surname>Rossi</surname><given-names>E.</given-names></name><name><surname>Frigeni</surname><given-names>B.</given-names></name><name><surname>Alberti</surname><given-names>P.</given-names></name><name><surname>Bruna</surname><given-names>J.</given-names></name><name><surname>Velasco</surname><given-names>R.</given-names></name><name><surname>Argyriou</surname><given-names>A.A.</given-names></name><etal/></person-group>
<article-title>The chemotherapy-induced peripheral neuropathy outcome measures standardization study: From consensus to the first validity and reliability findings</article-title>
<source>Ann. Oncol.</source>
<year>2013</year>
<volume>24</volume>
<fpage>454</fpage>
<lpage>462</lpage>
<pub-id pub-id-type="doi">10.1093/annonc/mds329</pub-id>
<?supplied-pmid 22910842?><pub-id pub-id-type="pmid">22910842</pub-id></element-citation></ref><ref id="B13-molecules-21-01252"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hausheer</surname><given-names>F.H.</given-names></name><name><surname>Schilsky</surname><given-names>R.L.</given-names></name><name><surname>Bain</surname><given-names>S.</given-names></name><name><surname>Berghorn</surname><given-names>E.J.</given-names></name><name><surname>Lieberman</surname><given-names>F.</given-names></name></person-group>
<article-title>Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy</article-title>
<source>Semin. Oncol.</source>
<year>2006</year>
<volume>33</volume>
<fpage>15</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1053/j.seminoncol.2005.12.010</pub-id>
<?supplied-pmid 16473643?><pub-id pub-id-type="pmid">16473643</pub-id></element-citation></ref><ref id="B14-molecules-21-01252"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grothey</surname><given-names>A.</given-names></name></person-group>
<article-title>Clinical management of oxaliplatin-associated neurotoxicity</article-title>
<source>Clin. Colorectal Cancer</source>
<year>2005</year>
<volume>5</volume>
<issue>Suppl. 1</issue>
<fpage>S38</fpage>
<lpage>S46</lpage>
<pub-id pub-id-type="doi">10.3816/CCC.2005.s.006</pub-id>
<?supplied-pmid 15871765?><pub-id pub-id-type="pmid">15871765</pub-id></element-citation></ref><ref id="B15-molecules-21-01252"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kushlaf</surname><given-names>H.A.</given-names></name></person-group>
<article-title>Emerging toxic neuropathies and myopathies</article-title>
<source>Neurol. Clin.</source>
<year>2011</year>
<volume>29</volume>
<fpage>679</fpage>
<lpage>687</lpage>
<pub-id pub-id-type="doi">10.1016/j.ncl.2011.05.009</pub-id>
<?supplied-pmid 21803218?><pub-id pub-id-type="pmid">21803218</pub-id></element-citation></ref><ref id="B16-molecules-21-01252"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuncl</surname><given-names>R.W.</given-names></name><name><surname>George</surname><given-names>E.B.</given-names></name></person-group>
<article-title>Toxic neuropathies and myopathies</article-title>
<source>Curr. Opin. Neurol.</source>
<year>1993</year>
<volume>6</volume>
<fpage>695</fpage>
<lpage>704</lpage>
<pub-id pub-id-type="doi">10.1097/00019052-199310000-00004</pub-id>
<?supplied-pmid 8293140?><pub-id pub-id-type="pmid">8293140</pub-id></element-citation></ref><ref id="B17-molecules-21-01252"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Flatters</surname><given-names>S.J.</given-names></name><name><surname>Xiao</surname><given-names>W.H.</given-names></name><name><surname>Bennett</surname><given-names>G.J.</given-names></name></person-group>
<article-title>Acetyl-l-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy</article-title>
<source>Neurosci. Lett.</source>
<year>2006</year>
<volume>397</volume>
<fpage>219</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2005.12.013</pub-id>
<?supplied-pmid 16406309?><pub-id pub-id-type="pmid">16406309</pub-id></element-citation></ref><ref id="B18-molecules-21-01252"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cavaletti</surname><given-names>G.</given-names></name></person-group>
<article-title>Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: Is it a trade-off between drug efficacy and toxicity?</article-title>
<source>Oncologist</source>
<year>2011</year>
<volume>16</volume>
<fpage>1667</fpage>
<lpage>1668</lpage>
<pub-id pub-id-type="doi">10.1634/theoncologist.2011-0343</pub-id>
<?supplied-pmid 22128117?><pub-id pub-id-type="pmid">22128117</pub-id></element-citation></ref><ref id="B19-molecules-21-01252"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ta</surname><given-names>L.E.</given-names></name><name><surname>Schmelzer</surname><given-names>J.D.</given-names></name><name><surname>Bieber</surname><given-names>A.J.</given-names></name><name><surname>Loprinzi</surname><given-names>C.L.</given-names></name><name><surname>Sieck</surname><given-names>G.C.</given-names></name><name><surname>Brederson</surname><given-names>J.D.</given-names></name><name><surname>Low</surname><given-names>P.A.</given-names></name><name><surname>Windebank</surname><given-names>A.J.</given-names></name></person-group>
<article-title>A novel and selective poly(adp-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy</article-title>
<source>PLoS ONE</source>
<year>2013</year>
<volume>8</volume>
<elocation-id>e54161</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0054161</pub-id>
<?supplied-pmid 23326593?><pub-id pub-id-type="pmid">23326593</pub-id></element-citation></ref><ref id="B20-molecules-21-01252"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wolf</surname><given-names>S.</given-names></name><name><surname>Barton</surname><given-names>D.</given-names></name><name><surname>Kottschade</surname><given-names>L.</given-names></name><name><surname>Grothey</surname><given-names>A.</given-names></name><name><surname>Loprinzi</surname><given-names>C.</given-names></name></person-group>
<article-title>Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies</article-title>
<source>Eur. J. Cancer</source>
<year>2008</year>
<volume>44</volume>
<fpage>1507</fpage>
<lpage>1515</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejca.2008.04.018</pub-id>
<?supplied-pmid 18571399?><pub-id pub-id-type="pmid">18571399</pub-id></element-citation></ref><ref id="B21-molecules-21-01252"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ceresa</surname><given-names>C.</given-names></name><name><surname>Cavaletti</surname><given-names>G.</given-names></name></person-group>
<article-title>Drug transporters in chemotherapy induced peripheral neurotoxicity: Current knowledge and clinical implications</article-title>
<source>Curr. Med. Chem.</source>
<year>2011</year>
<volume>18</volume>
<fpage>329</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.2174/092986711794839160</pub-id>
<?supplied-pmid 21143122?><pub-id pub-id-type="pmid">21143122</pub-id></element-citation></ref><ref id="B22-molecules-21-01252"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>S.E.</given-names></name><name><surname>Tian</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group>
<article-title>Auraptenol attenuates vincristine-induced mechanical hyperalgesia through serotonin 5-ht1a receptors</article-title>
<source>Sci. Rep.</source>
<year>2013</year>
<volume>3</volume>
<fpage>3377</fpage>
<pub-id pub-id-type="doi">10.1038/srep03377</pub-id>
<?supplied-pmid 24287473?><pub-id pub-id-type="pmid">24287473</pub-id></element-citation></ref><ref id="B23-molecules-21-01252"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ward</surname><given-names>S.J.</given-names></name><name><surname>McAllister</surname><given-names>S.D.</given-names></name><name><surname>Kawamura</surname><given-names>R.</given-names></name><name><surname>Murase</surname><given-names>R.</given-names></name><name><surname>Neelakantan</surname><given-names>H.</given-names></name><name><surname>Walker</surname><given-names>E.A.</given-names></name></person-group>
<article-title>Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy</article-title>
<source>Br. J. Pharmacol.</source>
<year>2014</year>
<volume>171</volume>
<fpage>636</fpage>
<lpage>645</lpage>
<pub-id pub-id-type="doi">10.1111/bph.12439</pub-id>
<?supplied-pmid 24117398?><pub-id pub-id-type="pmid">24117398</pub-id></element-citation></ref><ref id="B24-molecules-21-01252"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al Moundhri</surname><given-names>M.S.</given-names></name><name><surname>Al-Salam</surname><given-names>S.</given-names></name><name><surname>Al Mahrouqee</surname><given-names>A.</given-names></name><name><surname>Beegam</surname><given-names>S.</given-names></name><name><surname>Ali</surname><given-names>B.H.</given-names></name></person-group>
<article-title>The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: Some behavioral, biochemical, and histopathological studies</article-title>
<source>J. Med. Toxicol.</source>
<year>2013</year>
<volume>9</volume>
<fpage>25</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1007/s13181-012-0239-x</pub-id>
<?supplied-pmid 22648527?><pub-id pub-id-type="pmid">22648527</pub-id></element-citation></ref><ref id="B25-molecules-21-01252"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Azevedo</surname><given-names>M.I.</given-names></name><name><surname>Pereira</surname><given-names>A.F.</given-names></name><name><surname>Nogueira</surname><given-names>R.B.</given-names></name><name><surname>Rolim</surname><given-names>F.E.</given-names></name><name><surname>Brito</surname><given-names>G.A.</given-names></name><name><surname>Wong</surname><given-names>D.V.</given-names></name><name><surname>Lima-Junior</surname><given-names>R.C.</given-names></name><name><surname>de Albuquerque Ribeiro</surname><given-names>R.</given-names></name><name><surname>Vale</surname><given-names>M.L.</given-names></name></person-group>
<article-title>The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy</article-title>
<source>Mol. Pain</source>
<year>2013</year>
<volume>9</volume>
<fpage>53</fpage>
<pub-id pub-id-type="doi">10.1186/1744-8069-9-53</pub-id>
<?supplied-pmid 24152430?><pub-id pub-id-type="pmid">24152430</pub-id></element-citation></ref><ref id="B26-molecules-21-01252"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>F.Z.</given-names></name><name><surname>Xu</surname><given-names>S.Z.</given-names></name><name><surname>Wang</surname><given-names>L.J.</given-names></name><name><surname>Chen</surname><given-names>C.T.</given-names></name><name><surname>Zhou</surname><given-names>X.Q.</given-names></name><name><surname>Lu</surname><given-names>Y.Z.</given-names></name><name><surname>Zhang</surname><given-names>H.H.</given-names></name></person-group>
<article-title>Antinociceptive efficacy of verticinone in murine models of inflammatory pain and paclitaxel induced neuropathic pain</article-title>
<source>Biol. Pharm. Bull.</source>
<year>2011</year>
<volume>34</volume>
<fpage>1377</fpage>
<lpage>1382</lpage>
<pub-id pub-id-type="doi">10.1248/bpb.34.1377</pub-id>
<?supplied-pmid 21881221?><pub-id pub-id-type="pmid">21881221</pub-id></element-citation></ref><ref id="B27-molecules-21-01252"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ameyaw</surname><given-names>E.O.</given-names></name><name><surname>Woode</surname><given-names>E.</given-names></name><name><surname>Boakye-Gyasi</surname><given-names>E.</given-names></name><name><surname>Abotsi</surname><given-names>W.K.</given-names></name><name><surname>Kyekyeku</surname><given-names>J.O.</given-names></name><name><surname>Adosraku</surname><given-names>R.K.</given-names></name></person-group>
<article-title>Anti-allodynic and anti-hyperalgesic effects of an ethanolic extract and xylopic acid from the fruits of <italic>Xylopia aethiopica</italic> in murine models of neuropathic pain</article-title>
<source>Pharm. Res.</source>
<year>2014</year>
<volume>6</volume>
<fpage>172</fpage>
<lpage>179</lpage>
</element-citation></ref><ref id="B28-molecules-21-01252"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muthuraman</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name></person-group>
<article-title>Attenuating effect of hydroalcoholic extract of <italic>Acorus calamus</italic> in vincristine-induced painful neuropathy in rats</article-title>
<source>J. Nat. Med.</source>
<year>2011</year>
<volume>65</volume>
<fpage>480</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="doi">10.1007/s11418-011-0525-y</pub-id>
<?supplied-pmid 21404093?><pub-id pub-id-type="pmid">21404093</pub-id></element-citation></ref><ref id="B29-molecules-21-01252"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thiagarajan</surname><given-names>V.R.</given-names></name><name><surname>Shanmugam</surname><given-names>P.</given-names></name><name><surname>Krishnan</surname><given-names>U.M.</given-names></name><name><surname>Muthuraman</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name></person-group>
<article-title>Antinociceptive effect of <italic>Butea monosperma</italic> on vincristine-induced neuropathic pain model in rats</article-title>
<source>Toxicol. Ind. Health</source>
<year>2013</year>
<volume>29</volume>
<fpage>3</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1177/0748233711432573</pub-id>
<?supplied-pmid 22287618?><pub-id pub-id-type="pmid">22287618</pub-id></element-citation></ref><ref id="B30-molecules-21-01252"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>H.J.</given-names></name><name><surname>Lee</surname><given-names>H.G.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Jeon</surname><given-names>J.P.</given-names></name><name><surname>Park</surname><given-names>C.</given-names></name><name><surname>Moon</surname><given-names>D.E.</given-names></name></person-group>
<article-title><italic>Ginkgo biloba</italic> extract attenuates hyperalgesia in a rat model of vincristine-induced peripheral neuropathy</article-title>
<source>Anesthesia Analg.</source>
<year>2012</year>
<volume>115</volume>
<fpage>1228</fpage>
<lpage>1233</lpage>
<pub-id pub-id-type="doi">10.1213/ANE.0b013e318262e170</pub-id>
<?supplied-pmid 23011564?><pub-id pub-id-type="pmid">23011564</pub-id></element-citation></ref><ref id="B31-molecules-21-01252"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ozturk</surname><given-names>G.</given-names></name><name><surname>Anlar</surname><given-names>O.</given-names></name><name><surname>Erdogan</surname><given-names>E.</given-names></name><name><surname>Kosem</surname><given-names>M.</given-names></name><name><surname>Ozbek</surname><given-names>H.</given-names></name><name><surname>Turker</surname><given-names>A.</given-names></name></person-group>
<article-title>The effect of ginkgo extract EGb761 in cisplatin-induced peripheral neuropathy in mice</article-title>
<source>Toxicol. Appl. Pharmacol.</source>
<year>2004</year>
<volume>196</volume>
<fpage>169</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1016/j.taap.2003.12.006</pub-id>
<?supplied-pmid 15050418?><pub-id pub-id-type="pmid">15050418</pub-id></element-citation></ref><ref id="B32-molecules-21-01252"><label>32.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>Y.T.</given-names></name><name><surname>Jeon</surname><given-names>E.K.</given-names></name><name><surname>Won</surname><given-names>H.S.</given-names></name><name><surname>Cho</surname><given-names>Y.S.</given-names></name><name><surname>Ko</surname><given-names>Y.H.</given-names></name></person-group>
<article-title>Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats</article-title>
<source>BMC Complement. Altern. Med.</source>
<year>2012</year>
<volume>12</volume>
<fpage>124</fpage>
<pub-id pub-id-type="doi">10.1186/1472-6882-12-124</pub-id>
<?supplied-pmid 22894541?><pub-id pub-id-type="pmid">22894541</pub-id></element-citation></ref><ref id="B33-molecules-21-01252"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Jaggi</surname><given-names>A.S.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name></person-group>
<article-title>Exploring the potential effect of <italic>Ocimum sanctum</italic> in vincristine-induced neuropathic pain in rats</article-title>
<source>J. Brachial Plex. Peripher. Nerve Inj.</source>
<year>2010</year>
<volume>5</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1186/1749-7221-5-3</pub-id>
<?supplied-pmid 20181005?><pub-id pub-id-type="pmid">20181005</pub-id></element-citation></ref><ref id="B34-molecules-21-01252"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Namvaran-Abbas-Abad</surname><given-names>A.</given-names></name><name><surname>Tavakkoli</surname><given-names>F.</given-names></name></person-group>
<article-title>Antinociceptive effect of salvia extract on cisplatin-induced hyperalgesia in mice</article-title>
<source>Neurophysiology</source>
<year>2012</year>
<volume>43</volume>
<fpage>452</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="doi">10.1007/s11062-012-9249-1</pub-id>
</element-citation></ref><ref id="B35-molecules-21-01252"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shabani</surname><given-names>M.</given-names></name><name><surname>Nazeri</surname><given-names>M.</given-names></name><name><surname>Parsania</surname><given-names>S.</given-names></name><name><surname>Razavinasab</surname><given-names>M.</given-names></name><name><surname>Zangiabadi</surname><given-names>N.</given-names></name><name><surname>Esmaeilpour</surname><given-names>K.</given-names></name><name><surname>Abareghi</surname><given-names>F.</given-names></name></person-group>
<article-title>Walnut consumption protects rats against cisplatin-induced neurotoxicity</article-title>
<source>Neurotoxicology</source>
<year>2012</year>
<volume>33</volume>
<fpage>1314</fpage>
<lpage>1321</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2012.08.004</pub-id>
<?supplied-pmid 22935099?><pub-id pub-id-type="pmid">22935099</pub-id></element-citation></ref><ref id="B36-molecules-21-01252"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ahn</surname><given-names>B.S.</given-names></name><name><surname>Kim</surname><given-names>S.K.</given-names></name><name><surname>Kim</surname><given-names>H.N.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Hwang</surname><given-names>D.S.</given-names></name><name><surname>Bae</surname><given-names>H.</given-names></name><name><surname>Min</surname><given-names>B.I.</given-names></name><name><surname>Kim</surname><given-names>S.K.</given-names></name></person-group>
<article-title>Gyejigachulbu-tang relieves oxaliplatin-induced neuropathic cold and mechanical hypersensitivity in rats via the suppression of spinal glial activation</article-title>
<source>Evid. Based Complement. Altern. Med.</source>
<year>2014</year>
<volume>2014</volume>
<fpage>436482</fpage>
<pub-id pub-id-type="doi">10.1155/2014/436482</pub-id>
<?supplied-pmid 25505922?><pub-id pub-id-type="pmid">25505922</pub-id></element-citation></ref><ref id="B37-molecules-21-01252"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name></person-group>
<article-title>Clinical study on the prevention of oxaliplatin-induced neurotoxicity with guilongtongluofang: Results of a randomized, double-blind, placebo-controlled trial</article-title>
<source>Evid. Based Complement. Altern. Med.</source>
<year>2013</year>
<volume>2013</volume>
<fpage>541217</fpage>
<pub-id pub-id-type="doi">10.1155/2013/541217</pub-id>
<?supplied-pmid 24324514?><pub-id pub-id-type="pmid">24324514</pub-id></element-citation></ref><ref id="B38-molecules-21-01252"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sima</surname><given-names>L.</given-names></name><name><surname>Pan</surname><given-names>L.</given-names></name></person-group>
<article-title>Influence of chinese herb ah on chemotherapy-induced peripheral neuropathy</article-title>
<source>Ann. Oncol.</source>
<year>2009</year>
<volume>20</volume>
<fpage>46</fpage>
<pub-id pub-id-type="pmid">19454460</pub-id></element-citation></ref><ref id="B39-molecules-21-01252"><label>39.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hidaka</surname><given-names>T.</given-names></name><name><surname>Shima</surname><given-names>T.</given-names></name><name><surname>Nagira</surname><given-names>K.</given-names></name><name><surname>Ieki</surname><given-names>M.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Aono</surname><given-names>Y.</given-names></name><name><surname>Kuraishi</surname><given-names>Y.</given-names></name><name><surname>Arai</surname><given-names>T.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name></person-group>
<article-title>Herbal medicine shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice</article-title>
<source>Eur. J. Pain</source>
<year>2009</year>
<volume>13</volume>
<fpage>22</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpain.2008.03.003</pub-id>
<?supplied-pmid 18472288?><pub-id pub-id-type="pmid">18472288</pub-id></element-citation></ref><ref id="B40-molecules-21-01252"><label>40.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fujii</surname><given-names>K.</given-names></name><name><surname>Okamoto</surname><given-names>S.</given-names></name><name><surname>Saitoh</surname><given-names>K.</given-names></name><name><surname>Sasaki</surname><given-names>N.</given-names></name><name><surname>Takano</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>S.</given-names></name><name><surname>Kudoh</surname><given-names>K.</given-names></name><name><surname>Kita</surname><given-names>T.</given-names></name><name><surname>Tode</surname><given-names>T.</given-names></name><name><surname>Kikuchi</surname><given-names>Y.</given-names></name></person-group>
<article-title>The efficacy of shakuyaku-kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma</article-title>
<source>Gan To Kagaku Ryoho. Cancer Chemother.</source>
<year>2004</year>
<volume>31</volume>
<fpage>1537</fpage>
<lpage>1540</lpage>
</element-citation></ref><ref id="B41-molecules-21-01252"><label>41.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ushio</surname><given-names>S.</given-names></name><name><surname>Egashira</surname><given-names>N.</given-names></name><name><surname>Sada</surname><given-names>H.</given-names></name><name><surname>Kawashiri</surname><given-names>T.</given-names></name><name><surname>Shirahama</surname><given-names>M.</given-names></name><name><surname>Masuguchi</surname><given-names>K.</given-names></name><name><surname>Oishi</surname><given-names>R.</given-names></name></person-group>
<article-title>Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents</article-title>
<source>Eur. J. Cancer</source>
<year>2012</year>
<volume>48</volume>
<fpage>1407</fpage>
<lpage>1413</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejca.2011.08.009</pub-id>
<?supplied-pmid 21907570?><pub-id pub-id-type="pmid">21907570</pub-id></element-citation></ref><ref id="B42-molecules-21-01252"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kono</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Mizuno</surname><given-names>K.</given-names></name><name><surname>Miyagi</surname><given-names>C.</given-names></name><name><surname>Omiya</surname><given-names>Y.</given-names></name><name><surname>Sekine</surname><given-names>H.</given-names></name><name><surname>Mizuhara</surname><given-names>Y.</given-names></name><name><surname>Miyano</surname><given-names>K.</given-names></name><name><surname>Kase</surname><given-names>Y.</given-names></name><name><surname>Uezono</surname><given-names>Y.</given-names></name></person-group>
<article-title>Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats</article-title>
<source>Sci. Rep.</source>
<year>2015</year>
<volume>5</volume>
<fpage>16078</fpage>
<pub-id pub-id-type="doi">10.1038/srep16078</pub-id>
<?supplied-pmid 26542342?><pub-id pub-id-type="pmid">26542342</pub-id></element-citation></ref><ref id="B43-molecules-21-01252"><label>43.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bahar</surname><given-names>M.A.</given-names></name><name><surname>Andoh</surname><given-names>T.</given-names></name><name><surname>Ogura</surname><given-names>K.</given-names></name><name><surname>Hayakawa</surname><given-names>Y.</given-names></name><name><surname>Saiki</surname><given-names>I.</given-names></name><name><surname>Kuraishi</surname><given-names>Y.</given-names></name></person-group>
<article-title>Herbal medicine goshajinkigan prevents paclitaxel-induced mechanical allodynia without impairing antitumor activity of paclitaxel</article-title>
<source>Evid. Based Complement. Altern. Med.</source>
<year>2013</year>
<pub-id pub-id-type="doi">10.1155/2013/849754</pub-id>
<?supplied-pmid 24198846?><pub-id pub-id-type="pmid">24198846</pub-id></element-citation></ref><ref id="B44-molecules-21-01252"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kono</surname><given-names>T.</given-names></name><name><surname>Mamiya</surname><given-names>N.</given-names></name><name><surname>Chisato</surname><given-names>N.</given-names></name><name><surname>Ebisawa</surname><given-names>Y.</given-names></name><name><surname>Yamazaki</surname><given-names>H.</given-names></name><name><surname>Watari</surname><given-names>J.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>S.</given-names></name><name><surname>Asama</surname><given-names>T.</given-names></name><name><surname>Kamiya</surname><given-names>K.</given-names></name></person-group>
<article-title>Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer</article-title>
<source>Evid. Based Complement. Altern. Med.</source>
<year>2011</year>
<volume>2011</volume>
<fpage>418481</fpage>
<pub-id pub-id-type="doi">10.1093/ecam/nep200</pub-id>
<?supplied-pmid 19952054?><pub-id pub-id-type="pmid">19952054</pub-id></element-citation></ref><ref id="B45-molecules-21-01252"><label>45.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kono</surname><given-names>T.</given-names></name><name><surname>Hata</surname><given-names>T.</given-names></name><name><surname>Morita</surname><given-names>S.</given-names></name><name><surname>Munemoto</surname><given-names>Y.</given-names></name><name><surname>Matsui</surname><given-names>T.</given-names></name><name><surname>Kojima</surname><given-names>H.</given-names></name><name><surname>Takemoto</surname><given-names>H.</given-names></name><name><surname>Fukunaga</surname><given-names>M.</given-names></name><name><surname>Nagata</surname><given-names>N.</given-names></name><name><surname>Shimada</surname><given-names>M.</given-names></name><etal/></person-group>
<article-title>Goshajinkigan oxaliplatin neurotoxicity evaluation (gone): A phase 2, multicenter, randomized, doubleblind, placebocontrolled trial of goshajinkigan to prevent oxaliplatininduced neuropathy</article-title>
<source>Cancer Chemother. Pharmacol.</source>
<year>2013</year>
<volume>72</volume>
<fpage>1283</fpage>
<lpage>1290</lpage>
<pub-id pub-id-type="doi">10.1007/s00280-013-2306-7</pub-id>
<?supplied-pmid 24121454?><pub-id pub-id-type="pmid">24121454</pub-id></element-citation></ref><ref id="B46-molecules-21-01252"><label>46.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>N.</given-names></name><name><surname>Hosokawa</surname><given-names>T.</given-names></name><name><surname>Ishikawa</surname><given-names>T.</given-names></name><name><surname>Yagi</surname><given-names>N.</given-names></name><name><surname>Kokura</surname><given-names>S.</given-names></name><name><surname>Naito</surname><given-names>Y.</given-names></name><name><surname>Nakanishi</surname><given-names>M.</given-names></name><name><surname>Kokuba</surname><given-names>Y.</given-names></name><name><surname>Otsuji</surname><given-names>E.</given-names></name><name><surname>Kuroboshi</surname><given-names>H.</given-names></name><etal/></person-group>
<article-title>Efficacy of goshajinkigan for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients</article-title>
<source>J. Oncol.</source>
<year>2013</year>
<volume>2013</volume>
<fpage>139740</fpage>
<pub-id pub-id-type="doi">10.1155/2013/139740</pub-id>
<?supplied-pmid 24307899?><pub-id pub-id-type="pmid">24307899</pub-id></element-citation></ref><ref id="B47-molecules-21-01252"><label>47.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hosokawa</surname><given-names>A.</given-names></name><name><surname>Ogawa</surname><given-names>K.</given-names></name><name><surname>Ando</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>Ueda</surname><given-names>A.</given-names></name><name><surname>Kajiura</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>Y.</given-names></name><name><surname>Tsukioka</surname><given-names>Y.</given-names></name><name><surname>Horikawa</surname><given-names>N.</given-names></name><name><surname>Yabushita</surname><given-names>K.</given-names></name><etal/></person-group>
<article-title>Preventive effect of traditional japanese medicine on neurotoxicity of folfox for metastatic colorectal cancer: A multicenter retrospective study</article-title>
<source>Anticancer Res.</source>
<year>2012</year>
<volume>32</volume>
<fpage>2545</fpage>
<lpage>2550</lpage>
<?supplied-pmid 22753712?><pub-id pub-id-type="pmid">22753712</pub-id></element-citation></ref><ref id="B48-molecules-21-01252"><label>48.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Murai</surname><given-names>T.</given-names></name><name><surname>Ueda</surname><given-names>M.</given-names></name><name><surname>Katsuura</surname><given-names>M.</given-names></name><name><surname>Oishi</surname><given-names>M.</given-names></name><name><surname>Miwa</surname><given-names>Y.</given-names></name><name><surname>Okamoto</surname><given-names>Y.</given-names></name><name><surname>Uejima</surname><given-names>E.</given-names></name><name><surname>Taguchi</surname><given-names>T.</given-names></name><name><surname>Noguchi</surname><given-names>S.</given-names></name><etal/></person-group>
<article-title>Clinical features of paclitaxel-induced peripheral neuropathy and role of gosya-jinki-gan</article-title>
<source>Gan To kagaku ryoho. Cancer Chemother.</source>
<year>2009</year>
<volume>36</volume>
<fpage>89</fpage>
<lpage>92</lpage>
</element-citation></ref><ref id="B49-molecules-21-01252"><label>49.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jordan</surname><given-names>M.A.</given-names></name></person-group>
<article-title>Mechanism of action of antitumor drugs that interact with microtubules and tubulin</article-title>
<source>Curr. Med. Chem. Anti-Cancer Agent.</source>
<year>2002</year>
<volume>2</volume>
<fpage>1</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.2174/1568011023354290</pub-id>
</element-citation></ref><ref id="B50-molecules-21-01252"><label>50.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verstappen</surname><given-names>C.C.</given-names></name><name><surname>Koeppen</surname><given-names>S.</given-names></name><name><surname>Heimans</surname><given-names>J.J.</given-names></name><name><surname>Huijgens</surname><given-names>P.C.</given-names></name><name><surname>Scheulen</surname><given-names>M.E.</given-names></name><name><surname>Strumberg</surname><given-names>D.</given-names></name><name><surname>Kiburg</surname><given-names>B.</given-names></name><name><surname>Postma</surname><given-names>T.J.</given-names></name></person-group>
<article-title>Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening</article-title>
<source>Neurology</source>
<year>2005</year>
<volume>64</volume>
<fpage>1076</fpage>
<lpage>1077</lpage>
<pub-id pub-id-type="doi">10.1212/01.WNL.0000154642.45474.28</pub-id>
<?supplied-pmid 15781834?><pub-id pub-id-type="pmid">15781834</pub-id></element-citation></ref><ref id="B51-molecules-21-01252"><label>51.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharma</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>I.</given-names></name><name><surname>Chaudhary</surname><given-names>P.</given-names></name></person-group>
<article-title><italic>Acorus calamus</italic> (the healing plant): A review on its medicinal potential, micropropagation and conservation</article-title>
<source>Nat. Prod. Res.</source>
<year>2014</year>
<volume>28</volume>
<fpage>1454</fpage>
<lpage>1466</lpage>
<pub-id pub-id-type="doi">10.1080/14786419.2014.915827</pub-id>
<?supplied-pmid 24824923?><pub-id pub-id-type="pmid">24824923</pub-id></element-citation></ref><ref id="B52-molecules-21-01252"><label>52.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shah</surname><given-names>P.D.</given-names></name><name><surname>Ghag</surname><given-names>M.</given-names></name><name><surname>Deshmukh</surname><given-names>P.B.</given-names></name><name><surname>Kulkarni</surname><given-names>Y.</given-names></name><name><surname>Joshi</surname><given-names>S.V.</given-names></name><name><surname>Vyas</surname><given-names>B.A.</given-names></name><name><surname>Shah</surname><given-names>D.R.</given-names></name></person-group>
<article-title>Toxicity study of ethanolic extract of <italic>Acorus calamus rhizome</italic></article-title>
<source>Int. J. Green Pharm.</source>
<year>2014</year>
<volume>6</volume>
<fpage>38</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.4103/0973-8258.97119</pub-id>
</element-citation></ref><ref id="B53-molecules-21-01252"><label>53.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Dai</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Xie</surname><given-names>C.</given-names></name></person-group>
<article-title>Pharmacological studies on the chinese drug radix <italic>Angelicae dahuricae</italic></article-title>
<source>Zhongguo Zhong Yao Za Zhi</source>
<year>1991</year>
<volume>16</volume>
<fpage>560</fpage>
<lpage>576</lpage>
<page-range>560&#x02013;562, 576</page-range>
<?supplied-pmid 1804207?><pub-id pub-id-type="pmid">1804207</pub-id></element-citation></ref><ref id="B54-molecules-21-01252"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nie</surname><given-names>H.</given-names></name><name><surname>Shen</surname><given-names>Y.J.</given-names></name></person-group>
<article-title>Effect of essential oil of radix <italic>Angelicae dahuricae</italic> on beta-endorphin, acth, no and proopiomelanocortin of pain model rats</article-title>
<source>Zhongguo Zhong Yao Za Zhi</source>
<year>2002</year>
<volume>27</volume>
<fpage>690</fpage>
<lpage>693</lpage>
<?supplied-pmid 12776573?><pub-id pub-id-type="pmid">12776573</pub-id></element-citation></ref><ref id="B55-molecules-21-01252"><label>55.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yuan</surname><given-names>C.S.</given-names></name><name><surname>Mehendale</surname><given-names>S.R.</given-names></name><name><surname>Wang</surname><given-names>C.Z.</given-names></name><name><surname>Aung</surname><given-names>H.H.</given-names></name><name><surname>Jiang</surname><given-names>T.</given-names></name><name><surname>Guan</surname><given-names>X.</given-names></name><name><surname>Shoyama</surname><given-names>Y.</given-names></name></person-group>
<article-title>Effects of <italic>Corydalis yanhusuo</italic> and <italic>Angelicae dahuricae</italic> on cold pressor-induced pain in humans: A controlled trial</article-title>
<source>J. Clin. Pharmacol.</source>
<year>2004</year>
<volume>44</volume>
<fpage>1323</fpage>
<lpage>1327</lpage>
<pub-id pub-id-type="doi">10.1177/0091270004267809</pub-id>
<?supplied-pmid 15496650?><pub-id pub-id-type="pmid">15496650</pub-id></element-citation></ref><ref id="B56-molecules-21-01252"><label>56.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Akram</surname><given-names>M.</given-names></name><name><surname>Akhtar</surname><given-names>N.</given-names></name><name><surname>Asif</surname><given-names>H.M.</given-names></name><name><surname>Shah</surname><given-names>P.A.</given-names></name><name><surname>Saeed</surname><given-names>T.</given-names></name><name><surname>Mahmood</surname><given-names>A.</given-names></name><name><surname>Malik</surname><given-names>N.S.</given-names></name></person-group>
<article-title><italic>Butea monosperma</italic> lam.: A review</article-title>
<source>J. Med. Plants Res.</source>
<year>2011</year>
<volume>5</volume>
<fpage>3994</fpage>
<lpage>3996</lpage>
</element-citation></ref><ref id="B57-molecules-21-01252"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Madhavi</surname><given-names>A.</given-names></name></person-group>
<article-title>An overview of <italic>Butea monosperma</italic> (flame of forest)</article-title>
<source>World J. Pharm. Pharm. Sci.</source>
<year>2013</year>
<volume>3</volume>
<fpage>307</fpage>
<lpage>319</lpage>
</element-citation></ref><ref id="B58-molecules-21-01252"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahn</surname><given-names>E.J.</given-names></name><name><surname>Hohmann</surname><given-names>A.G.</given-names></name></person-group>
<article-title>Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside</article-title>
<source>Neurotherapeutics</source>
<year>2009</year>
<volume>6</volume>
<fpage>713</fpage>
<lpage>737</lpage>
<pub-id pub-id-type="doi">10.1016/j.nurt.2009.08.002</pub-id>
<?supplied-pmid 19789075?><pub-id pub-id-type="pmid">19789075</pub-id></element-citation></ref><ref id="B59-molecules-21-01252"><label>59.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagarkatti</surname><given-names>P.</given-names></name><name><surname>Pandey</surname><given-names>R.</given-names></name><name><surname>Rieder</surname><given-names>S.A.</given-names></name><name><surname>Hegde</surname><given-names>V.L.</given-names></name><name><surname>Nagarkatti</surname><given-names>M.</given-names></name></person-group>
<article-title>Cannabinoids as novel anti-inflammatory drugs</article-title>
<source>Future Med. Chem.</source>
<year>2009</year>
<volume>1</volume>
<fpage>1333</fpage>
<lpage>1349</lpage>
<pub-id pub-id-type="doi">10.4155/fmc.09.93</pub-id>
<?supplied-pmid 20191092?><pub-id pub-id-type="pmid">20191092</pub-id></element-citation></ref><ref id="B60-molecules-21-01252"><label>60.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahn</surname><given-names>E.J.</given-names></name><name><surname>Makriyannis</surname><given-names>A.</given-names></name><name><surname>Hohmann</surname><given-names>A.G.</given-names></name></person-group>
<article-title>Activation of cannabinoid cb1 and cb2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats</article-title>
<source>Br. J. Pharmacol.</source>
<year>2007</year>
<volume>152</volume>
<fpage>765</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjp.0707333</pub-id>
<?supplied-pmid 17572696?><pub-id pub-id-type="pmid">17572696</pub-id></element-citation></ref><ref id="B61-molecules-21-01252"><label>61.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Velasco</surname><given-names>G.</given-names></name><name><surname>Hernandez-Tiedra</surname><given-names>S.</given-names></name><name><surname>Davila</surname><given-names>D.</given-names></name><name><surname>Lorente</surname><given-names>M.</given-names></name></person-group>
<article-title>The use of cannabinoids as anticancer agents</article-title>
<source>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</source>
<year>2016</year>
<volume>64</volume>
<fpage>259</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2015.05.010</pub-id>
<?supplied-pmid 26071989?><pub-id pub-id-type="pmid">26071989</pub-id></element-citation></ref><ref id="B62-molecules-21-01252"><label>62.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Isah</surname><given-names>T.</given-names></name></person-group>
<article-title>Rethinking <italic>Ginkgo biloba</italic> L.: Medicinal uses and conservation</article-title>
<source>Pharm. Rev.</source>
<year>2015</year>
<volume>9</volume>
<fpage>140</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.4103/0973-7847.162137</pub-id>
<?supplied-pmid 26392712?><pub-id pub-id-type="pmid">26392712</pub-id></element-citation></ref><ref id="B63-molecules-21-01252"><label>63.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Qiu</surname><given-names>W.L.</given-names></name><name><surname>Wang</surname><given-names>Y.S.</given-names></name><name><surname>Cong</surname><given-names>Q.</given-names></name><name><surname>Edwards</surname><given-names>D.</given-names></name><name><surname>Ye</surname><given-names>B.</given-names></name><name><surname>Xu</surname><given-names>C.J.</given-names></name></person-group>
<article-title>Ginkgo may prevent genetic-associated ovarian cancer risk: Multiple biomarkers and anticancer pathways induced by ginkgolide b in brca1-mutant ovarian epithelial cells</article-title>
<source>Eur. J. Cancer Prev.</source>
<year>2011</year>
<volume>20</volume>
<fpage>508</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="doi">10.1097/CEJ.0b013e328348fbb7</pub-id>
<?supplied-pmid 21857521?><pub-id pub-id-type="pmid">21857521</pub-id></element-citation></ref><ref id="B64-molecules-21-01252"><label>64.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marques</surname><given-names>F.</given-names></name><name><surname>Azevedo</surname><given-names>F.</given-names></name><name><surname>Johansson</surname><given-names>B.</given-names></name><name><surname>Oliveira</surname><given-names>R.</given-names></name></person-group>
<article-title>Stimulation of DNA repair in saccharomyces cerevisiae by <italic>Ginkgo biloba</italic> leaf extract</article-title>
<source>Food Chem. Toxicol.</source>
<year>2011</year>
<volume>49</volume>
<fpage>1361</fpage>
<lpage>1366</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2011.03.020</pub-id>
<?supplied-pmid 21419822?><pub-id pub-id-type="pmid">21419822</pub-id></element-citation></ref><ref id="B65-molecules-21-01252"><label>65.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Esmekaya</surname><given-names>M.A.</given-names></name><name><surname>Aytekin</surname><given-names>E.</given-names></name><name><surname>Ozgur</surname><given-names>E.</given-names></name><name><surname>Guler</surname><given-names>G.</given-names></name><name><surname>Ergun</surname><given-names>M.A.</given-names></name><name><surname>Omeroglu</surname><given-names>S.</given-names></name><name><surname>Seyhan</surname><given-names>N.</given-names></name></person-group>
<article-title>Mutagenic and morphologic impacts of 1.8 ghz radiofrequency radiation on human peripheral blood lymphocytes (hPBLs) and possible protective role of pre-treatment with <italic>Ginkgo biloba</italic> (EGb 761)</article-title>
<source>Sci. Total Environ.</source>
<year>2011</year>
<volume>410</volume>
<fpage>59</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/j.scitotenv.2011.09.036</pub-id>
<?supplied-pmid 22014767?><pub-id pub-id-type="pmid">22014767</pub-id></element-citation></ref><ref id="B66-molecules-21-01252"><label>66.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Biggs</surname><given-names>M.L.</given-names></name><name><surname>Sorkin</surname><given-names>B.C.</given-names></name><name><surname>Nahin</surname><given-names>R.L.</given-names></name><name><surname>Kuller</surname><given-names>L.H.</given-names></name><name><surname>Fitzpatrick</surname><given-names>A.L.</given-names></name></person-group>
<article-title><italic>Ginkgo biloba</italic> and risk of cancer: Secondary analysis of the ginkgo evaluation of memory (gem) study</article-title>
<source>Pharmacoepidemiol. Drug Saf.</source>
<year>2010</year>
<volume>19</volume>
<fpage>694</fpage>
<lpage>698</lpage>
<pub-id pub-id-type="doi">10.1002/pds.1979</pub-id>
<?supplied-pmid 20582906?><pub-id pub-id-type="pmid">20582906</pub-id></element-citation></ref><ref id="B67-molecules-21-01252"><label>67.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pattanayak</surname><given-names>P.</given-names></name><name><surname>Behera</surname><given-names>P.</given-names></name><name><surname>Das</surname><given-names>D.</given-names></name><name><surname>Panda</surname><given-names>S.K.</given-names></name></person-group>
<article-title><italic>Ocimum sanctum</italic> linn. A reservoir plant for therapeutic applications: An overview</article-title>
<source>Pharm. Rev.</source>
<year>2010</year>
<volume>4</volume>
<fpage>95</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.4103/0973-7847.65323</pub-id>
<?supplied-pmid 22228948?><pub-id pub-id-type="pmid">22228948</pub-id></element-citation></ref><ref id="B68-molecules-21-01252"><label>68.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kelm</surname><given-names>M.A.</given-names></name><name><surname>Nair</surname><given-names>M.G.</given-names></name><name><surname>Strasburg</surname><given-names>G.M.</given-names></name><name><surname>DeWitt</surname><given-names>D.L.</given-names></name></person-group>
<article-title>Antioxidant and cyclooxygenase inhibitory phenolic compounds from <italic>Ocimum sanctum</italic> linn.</article-title>
<source>Phytomedicine</source>
<year>2000</year>
<volume>7</volume>
<fpage>7</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/S0944-7113(00)80015-X</pub-id>
<pub-id pub-id-type="pmid">10782484</pub-id></element-citation></ref><ref id="B69-molecules-21-01252"><label>69.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prakash</surname><given-names>J.</given-names></name><name><surname>Gupta</surname><given-names>S.K.</given-names></name></person-group>
<article-title>Chemopreventive activity of <italic>Ocimum sanctum</italic> seed oil</article-title>
<source>J. Ethnopharmacol.</source>
<year>2000</year>
<volume>72</volume>
<fpage>29</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-8741(00)00194-X</pub-id>
<pub-id pub-id-type="pmid">10967450</pub-id></element-citation></ref><ref id="B70-molecules-21-01252"><label>70.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Igwe</surname><given-names>S.A.</given-names></name><name><surname>Afonne</surname><given-names>J.C.</given-names></name><name><surname>Ghasi</surname><given-names>S.I.</given-names></name></person-group>
<article-title>Ocular dynamics of systemic aqueous extracts of <italic>Xylopia aethiopica</italic> (african guinea pepper) seeds on visually active volunteers</article-title>
<source>J. Ethnopharm.</source>
<year>2003</year>
<volume>86</volume>
<fpage>139</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-8741(02)00371-9</pub-id>
</element-citation></ref><ref id="B71-molecules-21-01252"><label>71.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adaramoye</surname><given-names>O.A.</given-names></name><name><surname>Sarkar</surname><given-names>J.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name><name><surname>Meena</surname><given-names>S.</given-names></name><name><surname>Changkija</surname><given-names>B.</given-names></name><name><surname>Yadav</surname><given-names>P.P.</given-names></name><name><surname>Kanojiya</surname><given-names>S.</given-names></name><name><surname>Sinha</surname><given-names>S.</given-names></name></person-group>
<article-title>Antiproliferative action of <italic>Xylopia aethiopica</italic> fruit extract on human cervical cancer cells</article-title>
<source>Phytother. Res.</source>
<year>2011</year>
<volume>25</volume>
<fpage>1558</fpage>
<lpage>1563</lpage>
<pub-id pub-id-type="doi">10.1002/ptr.3551</pub-id>
<?supplied-pmid 21698670?><pub-id pub-id-type="pmid">21698670</pub-id></element-citation></ref><ref id="B72-molecules-21-01252"><label>72.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Choumessi</surname><given-names>A.T.</given-names></name><name><surname>Danel</surname><given-names>M.</given-names></name><name><surname>Chassaing</surname><given-names>S.</given-names></name><name><surname>Truchet</surname><given-names>I.</given-names></name><name><surname>Penlap</surname><given-names>V.B.</given-names></name><name><surname>Pieme</surname><given-names>A.C.</given-names></name><name><surname>Asonganyi</surname><given-names>T.</given-names></name><name><surname>Ducommun</surname><given-names>B.</given-names></name><name><surname>Valette</surname><given-names>A.</given-names></name></person-group>
<article-title>Characterization of the antiproliferative activity of <italic>Xylopia aethiopica</italic></article-title>
<source>Cell Div.</source>
<year>2012</year>
<volume>7</volume>
<fpage>8</fpage>
<pub-id pub-id-type="doi">10.1186/1747-1028-7-8</pub-id>
<?supplied-pmid 22409878?><pub-id pub-id-type="pmid">22409878</pub-id></element-citation></ref><ref id="B73-molecules-21-01252"><label>73.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cavalcanti</surname><given-names>B.C.</given-names></name><name><surname>Bezerra</surname><given-names>D.P.</given-names></name><name><surname>Magalhaes</surname><given-names>H.I.</given-names></name><name><surname>Moraes</surname><given-names>M.O.</given-names></name><name><surname>Lima</surname><given-names>M.A.</given-names></name><name><surname>Silveira</surname><given-names>E.R.</given-names></name><name><surname>Camara</surname><given-names>C.A.</given-names></name><name><surname>Rao</surname><given-names>V.S.</given-names></name><name><surname>Pessoa</surname><given-names>C.</given-names></name><name><surname>Costa-Lotufo</surname><given-names>L.V.</given-names></name></person-group>
<article-title>Kauren-19-oic acid induces DNA damage followed by apoptosis in human leukemia cells</article-title>
<source>J. Appl. Toxicol.</source>
<year>2009</year>
<volume>29</volume>
<fpage>560</fpage>
<lpage>568</lpage>
<pub-id pub-id-type="doi">10.1002/jat.1439</pub-id>
<?supplied-pmid 19391104?><pub-id pub-id-type="pmid">19391104</pub-id></element-citation></ref><ref id="B74-molecules-21-01252"><label>74.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karasawa</surname><given-names>T.</given-names></name><name><surname>Steyger</surname><given-names>P.S.</given-names></name></person-group>
<article-title>An integrated view of cisplatin-induced nephrotoxicity and ototoxicity</article-title>
<source>Toxicol. Lett.</source>
<year>2015</year>
<volume>237</volume>
<fpage>219</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2015.06.012</pub-id>
<?supplied-pmid 26101797?><pub-id pub-id-type="pmid">26101797</pub-id></element-citation></ref><ref id="B75-molecules-21-01252"><label>75.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsang</surname><given-names>R.Y.</given-names></name><name><surname>Al-Fayea</surname><given-names>T.</given-names></name><name><surname>Au</surname><given-names>H.J.</given-names></name></person-group>
<article-title>Cisplatin overdose: Toxicities and management</article-title>
<source>Drug Saf.</source>
<year>2009</year>
<volume>32</volume>
<fpage>1109</fpage>
<lpage>1122</lpage>
<pub-id pub-id-type="doi">10.2165/11316640-000000000-00000</pub-id>
<?supplied-pmid 19916578?><pub-id pub-id-type="pmid">19916578</pub-id></element-citation></ref><ref id="B76-molecules-21-01252"><label>76.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ataie</surname><given-names>A.</given-names></name><name><surname>Sabetkasaei</surname><given-names>M.</given-names></name><name><surname>Haghparast</surname><given-names>A.</given-names></name><name><surname>Moghaddam</surname><given-names>A.H.</given-names></name><name><surname>Kazeminejad</surname><given-names>B.</given-names></name></person-group>
<article-title>Neuroprotective effects of the polyphenolic antioxidant agent, curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rat</article-title>
<source>Pharmacol. Biochem. Behav.</source>
<year>2010</year>
<volume>96</volume>
<fpage>378</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbb.2010.06.009</pub-id>
<?supplied-pmid 20619287?><pub-id pub-id-type="pmid">20619287</pub-id></element-citation></ref><ref id="B77-molecules-21-01252"><label>77.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Attia</surname><given-names>H.N.</given-names></name><name><surname>Al-Rasheed</surname><given-names>N.M.</given-names></name><name><surname>Al-Rasheed</surname><given-names>N.M.</given-names></name><name><surname>Maklad</surname><given-names>Y.A.</given-names></name><name><surname>Ahmed</surname><given-names>A.A.</given-names></name><name><surname>Kenawy</surname><given-names>S.A.</given-names></name></person-group>
<article-title>Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats</article-title>
<source>Behav. Pharmacol.</source>
<year>2012</year>
<volume>23</volume>
<fpage>153</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="doi">10.1097/FBP.0b013e3283512c00</pub-id>
<?supplied-pmid 22411174?><pub-id pub-id-type="pmid">22411174</pub-id></element-citation></ref><ref id="B78-molecules-21-01252"><label>78.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kandhare</surname><given-names>A.D.</given-names></name><name><surname>Raygude</surname><given-names>K.S.</given-names></name><name><surname>Ghosh</surname><given-names>P.</given-names></name><name><surname>Ghule</surname><given-names>A.E.</given-names></name><name><surname>Bodhankar</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Therapeutic role of curcumin in prevention of biochemical and behavioral aberration induced by alcoholic neuropathy in laboratory animals</article-title>
<source>Neurosci. Lett.</source>
<year>2012</year>
<volume>511</volume>
<fpage>18</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2012.01.019</pub-id>
<?supplied-pmid 22281447?><pub-id pub-id-type="pmid">22281447</pub-id></element-citation></ref><ref id="B79-molecules-21-01252"><label>79.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ravindran</surname><given-names>J.</given-names></name><name><surname>Prasad</surname><given-names>S.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group>
<article-title>Curcumin and cancer cells: How many ways can curry kill tumor cells selectively?</article-title>
<source>AAPS J.</source>
<year>2009</year>
<volume>11</volume>
<fpage>495</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="doi">10.1208/s12248-009-9128-x</pub-id>
<?supplied-pmid 19590964?><pub-id pub-id-type="pmid">19590964</pub-id></element-citation></ref><ref id="B80-molecules-21-01252"><label>80.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lopez-Lazaro</surname><given-names>M.</given-names></name></person-group>
<article-title>Anticancer and carcinogenic properties of curcumin: Considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent</article-title>
<source>Mol. Nutr. Food Res.</source>
<year>2008</year>
<volume>52</volume>
<issue>Suppl 1</issue>
<fpage>S103</fpage>
<lpage>S127</lpage>
<pub-id pub-id-type="doi">10.1002/mnfr.200700238</pub-id>
<?supplied-pmid 18496811?><pub-id pub-id-type="pmid">18496811</pub-id></element-citation></ref><ref id="B81-molecules-21-01252"><label>81.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R.A.</given-names></name><name><surname>Euden</surname><given-names>S.A.</given-names></name><name><surname>Platton</surname><given-names>S.L.</given-names></name><name><surname>Cooke</surname><given-names>D.N.</given-names></name><name><surname>Shafayat</surname><given-names>A.</given-names></name><name><surname>Hewitt</surname><given-names>H.R.</given-names></name><name><surname>Marczylo</surname><given-names>T.H.</given-names></name><name><surname>Morgan</surname><given-names>B.</given-names></name><name><surname>Hemingway</surname><given-names>D.</given-names></name><name><surname>Plummer</surname><given-names>S.M.</given-names></name><etal/></person-group>
<article-title>Phase i clinical trial of oral curcumin: Biomarkers of systemic activity and compliance</article-title>
<source>Clin. Cancer Res.</source>
<year>2004</year>
<volume>10</volume>
<fpage>6847</fpage>
<lpage>6854</lpage>
<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-0744</pub-id>
<?supplied-pmid 15501961?><pub-id pub-id-type="pmid">15501961</pub-id></element-citation></ref><ref id="B82-molecules-21-01252"><label>82.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Guha</surname><given-names>S.</given-names></name><name><surname>Krishnan</surname><given-names>S.</given-names></name><name><surname>Diagaradjane</surname><given-names>P.</given-names></name><name><surname>Gelovani</surname><given-names>J.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group>
<article-title>Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappab-regulated gene products</article-title>
<source>Cancer Res.</source>
<year>2007</year>
<volume>67</volume>
<fpage>3853</fpage>
<lpage>3861</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-4257</pub-id>
<?supplied-pmid 17440100?><pub-id pub-id-type="pmid">17440100</pub-id></element-citation></ref><ref id="B83-molecules-21-01252"><label>83.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dance-Barnes</surname><given-names>S.T.</given-names></name><name><surname>Kock</surname><given-names>N.D.</given-names></name><name><surname>Moore</surname><given-names>J.E.</given-names></name><name><surname>Lin</surname><given-names>E.Y.</given-names></name><name><surname>Mosley</surname><given-names>L.J.</given-names></name><name><surname>D&#x02019;Agostino</surname><given-names>R.B.</given-names><suffix>Jr.</suffix></name><name><surname>McCoy</surname><given-names>T.P.</given-names></name><name><surname>Townsend</surname><given-names>A.J.</given-names></name><name><surname>Miller</surname><given-names>M.S.</given-names></name></person-group>
<article-title>Lung tumor promotion by curcumin</article-title>
<source>Carcinogenesis</source>
<year>2009</year>
<volume>30</volume>
<fpage>1016</fpage>
<lpage>1023</lpage>
<pub-id pub-id-type="doi">10.1093/carcin/bgp082</pub-id>
<?supplied-pmid 19359593?><pub-id pub-id-type="pmid">19359593</pub-id></element-citation></ref><ref id="B84-molecules-21-01252"><label>84.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><collab>National Toxicology Program</collab></person-group>
<article-title>NTP toxicology and carcinogenesis studies of turmeric oleoresin (cas no. 8024-37-1) (major component 79%&#x02013;85% curcumin, cas no. 458-37-7) in F344/N rats and B6C3F1 mice (feed studies)</article-title>
<source>Nat. Toxicol. Program. Tech. Rep. Ser.</source>
<year>1993</year>
<volume>427</volume>
<fpage>1</fpage>
<lpage>275</lpage>
</element-citation></ref><ref id="B85-molecules-21-01252"><label>85.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miroddi</surname><given-names>M.</given-names></name><name><surname>Navarra</surname><given-names>M.</given-names></name><name><surname>Quattropani</surname><given-names>M.C.</given-names></name><name><surname>Calapai</surname><given-names>F.</given-names></name><name><surname>Gangemi</surname><given-names>S.</given-names></name><name><surname>Calapai</surname><given-names>G.</given-names></name></person-group>
<article-title>Systematic review of clinical trials assessing pharmacological properties of salvia species on memory, cognitive impairment and alzheimer&#x02019;s disease</article-title>
<source>CNS Neurosci. Ther.</source>
<year>2014</year>
<volume>20</volume>
<fpage>485</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="doi">10.1111/cns.12270</pub-id>
<?supplied-pmid 24836739?><pub-id pub-id-type="pmid">24836739</pub-id></element-citation></ref><ref id="B86-molecules-21-01252"><label>86.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perry</surname><given-names>N.B.</given-names></name><name><surname>Anderson</surname><given-names>R.E.</given-names></name><name><surname>Brennan</surname><given-names>N.J.</given-names></name><name><surname>Douglas</surname><given-names>M.H.</given-names></name><name><surname>Heaney</surname><given-names>A.J.</given-names></name><name><surname>McGimpsey</surname><given-names>J.A.</given-names></name><name><surname>Smallfield</surname><given-names>B.M.</given-names></name></person-group>
<article-title>Essential oils from dalmatian sage (<italic>Salvia officinalis</italic> L.): Variations among individuals, plant parts, seasons, and sites</article-title>
<source>J. Agric. Food Chem.</source>
<year>1999</year>
<volume>47</volume>
<fpage>2048</fpage>
<lpage>2054</lpage>
<pub-id pub-id-type="doi">10.1021/jf981170m</pub-id>
<?supplied-pmid 10552494?><pub-id pub-id-type="pmid">10552494</pub-id></element-citation></ref><ref id="B87-molecules-21-01252"><label>87.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abu-Darwish</surname><given-names>M.S.</given-names></name><name><surname>Cabral</surname><given-names>C.</given-names></name><name><surname>Ferreira</surname><given-names>I.V.</given-names></name><name><surname>Goncalves</surname><given-names>M.J.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Cruz</surname><given-names>M.T.</given-names></name><name><surname>Al-bdour</surname><given-names>T.H.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group>
<article-title>Essential oil of common sage (<italic>Salvia officinalis</italic> L.) from jordan: Assessment of safety in mammalian cells and its antifungal and anti-inflammatory potential</article-title>
<source>BioMed Res. Int.</source>
<year>2013</year>
<volume>2013</volume>
<fpage>538940</fpage>
<pub-id pub-id-type="doi">10.1155/2013/538940</pub-id>
<?supplied-pmid 24224168?><pub-id pub-id-type="pmid">24224168</pub-id></element-citation></ref><ref id="B88-molecules-21-01252"><label>88.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vujosevic</surname><given-names>M.</given-names></name><name><surname>Blagojevic</surname><given-names>J.</given-names></name></person-group>
<article-title>Antimutagenic effects of extracts from sage (<italic>Salvia officinalis</italic>) in mammalian system in vivo</article-title>
<source>Acta Vet. Hung.</source>
<year>2004</year>
<volume>52</volume>
<fpage>439</fpage>
<lpage>443</lpage>
<pub-id pub-id-type="doi">10.1556/AVet.52.2004.4.6</pub-id>
<?supplied-pmid 15595277?><pub-id pub-id-type="pmid">15595277</pub-id></element-citation></ref><ref id="B89-molecules-21-01252"><label>89.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keshavarz</surname><given-names>M.</given-names></name><name><surname>Bidmeshkipour</surname><given-names>A.</given-names></name><name><surname>Mostafaie</surname><given-names>A.</given-names></name><name><surname>Mansouri</surname><given-names>K.</given-names></name><name><surname>Mohammadi-Motlagh</surname><given-names>H.R.</given-names></name></person-group>
<article-title>Anti tumor activity of <italic>Salvia officinalis</italic> is due to its anti-angiogenic, anti-migratory and anti-proliferative effects</article-title>
<source>Yakhteh</source>
<year>2011</year>
<volume>12</volume>
<fpage>477</fpage>
<lpage>482</lpage>
</element-citation></ref><ref id="B90-molecules-21-01252"><label>90.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hardman</surname><given-names>W.E.</given-names></name><name><surname>Ion</surname><given-names>G.</given-names></name><name><surname>Akinsete</surname><given-names>J.A.</given-names></name><name><surname>Witte</surname><given-names>T.R.</given-names></name></person-group>
<article-title>Dietary walnut suppressed mammary gland tumorigenesis in the c(3)1 tag mouse</article-title>
<source>Nutr. Cancer</source>
<year>2011</year>
<volume>63</volume>
<fpage>960</fpage>
<lpage>970</lpage>
<pub-id pub-id-type="doi">10.1080/01635581.2011.589959</pub-id>
<?supplied-pmid 21774594?><pub-id pub-id-type="pmid">21774594</pub-id></element-citation></ref><ref id="B91-molecules-21-01252"><label>91.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hardman</surname><given-names>W.E.</given-names></name><name><surname>Ion</surname><given-names>G.</given-names></name></person-group>
<article-title>Suppression of implanted mda-mb 231 human breast cancer growth in nude mice by dietary walnut</article-title>
<source>Nutr. Cancer</source>
<year>2008</year>
<volume>60</volume>
<fpage>666</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="doi">10.1080/01635580802065302</pub-id>
<?supplied-pmid 18791931?><pub-id pub-id-type="pmid">18791931</pub-id></element-citation></ref><ref id="B92-molecules-21-01252"><label>92.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davis</surname><given-names>P.A.</given-names></name><name><surname>Vasu</surname><given-names>V.T.</given-names></name><name><surname>Gohil</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Khan</surname><given-names>I.H.</given-names></name><name><surname>Cross</surname><given-names>C.E.</given-names></name><name><surname>Yokoyama</surname><given-names>W.</given-names></name></person-group>
<article-title>A high-fat diet containing whole walnuts (<italic>Juglans regia</italic>) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model</article-title>
<source>Br. J. Nutr.</source>
<year>2012</year>
<volume>108</volume>
<fpage>1764</fpage>
<lpage>1772</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114511007288</pub-id>
<?supplied-pmid 22244053?><pub-id pub-id-type="pmid">22244053</pub-id></element-citation></ref><ref id="B93-molecules-21-01252"><label>93.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reiter</surname><given-names>R.J.</given-names></name><name><surname>Tan</surname><given-names>D.X.</given-names></name><name><surname>Manchester</surname><given-names>L.C.</given-names></name><name><surname>Korkmaz</surname><given-names>A.</given-names></name><name><surname>Fuentes-Broto</surname><given-names>L.</given-names></name><name><surname>Hardman</surname><given-names>W.E.</given-names></name><name><surname>Rosales-Corral</surname><given-names>S.A.</given-names></name><name><surname>Qi</surname><given-names>W.B.</given-names></name></person-group>
<article-title>A walnut-enriched diet reduces the growth of lncap human prostate cancer xenografts in nude mice</article-title>
<source>Cancer Investig.</source>
<year>2013</year>
<volume>31</volume>
<fpage>365</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.3109/07357907.2013.800095</pub-id>
<?supplied-pmid 23758186?><pub-id pub-id-type="pmid">23758186</pub-id></element-citation></ref><ref id="B94-molecules-21-01252"><label>94.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagel</surname><given-names>J.M.</given-names></name><name><surname>Brinkoetter</surname><given-names>M.</given-names></name><name><surname>Magkos</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Chamberland</surname><given-names>J.P.</given-names></name><name><surname>Shah</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>J.R.</given-names></name><name><surname>Blackburn</surname><given-names>G.</given-names></name><name><surname>Mantzoros</surname><given-names>C.S.</given-names></name></person-group>
<article-title>Dietary walnuts inhibit colorectal cancer growth in mice by suppressing angiogenesis</article-title>
<source>Nutrition</source>
<year>2012</year>
<volume>28</volume>
<fpage>67</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.nut.2011.03.004</pub-id>
<?supplied-pmid 21795022?><pub-id pub-id-type="pmid">21795022</pub-id></element-citation></ref><ref id="B95-molecules-21-01252"><label>95.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Becouarn</surname><given-names>Y.</given-names></name><name><surname>Ychou</surname><given-names>M.</given-names></name><name><surname>Ducreux</surname><given-names>M.</given-names></name><name><surname>Borel</surname><given-names>C.</given-names></name><name><surname>Bertheault-Cvitkovic</surname><given-names>F.</given-names></name><name><surname>Seitz</surname><given-names>J.F.</given-names></name><name><surname>Nasca</surname><given-names>S.</given-names></name><name><surname>Nguyen</surname><given-names>T.D.</given-names></name><name><surname>Paillot</surname><given-names>B.</given-names></name><name><surname>Raoul</surname><given-names>J.L.</given-names></name><etal/></person-group>
<article-title>Phase ii trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients</article-title>
<source>J. Clin. Oncol.</source>
<year>1998</year>
<volume>16</volume>
<fpage>2739</fpage>
<lpage>2744</lpage>
<?supplied-pmid 9704726?><pub-id pub-id-type="pmid">9704726</pub-id></element-citation></ref><ref id="B96-molecules-21-01252"><label>96.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Graham</surname><given-names>J.</given-names></name><name><surname>Muhsin</surname><given-names>M.</given-names></name><name><surname>Kirkpatrick</surname><given-names>P.</given-names></name></person-group>
<article-title>Oxaliplatin</article-title>
<source>Nat. Rev. Drug Discov.</source>
<year>2004</year>
<volume>3</volume>
<fpage>11</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1038/nrd1287</pub-id>
<?supplied-pmid 14756144?><pub-id pub-id-type="pmid">14756144</pub-id></element-citation></ref><ref id="B97-molecules-21-01252"><label>97.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pasetto</surname><given-names>L.M.</given-names></name><name><surname>D&#x02019;Andrea</surname><given-names>M.R.</given-names></name><name><surname>Rossi</surname><given-names>E.</given-names></name><name><surname>Monfardini</surname><given-names>S.</given-names></name></person-group>
<article-title>Oxaliplatin-related neurotoxicity: How and why?</article-title>
<source>Crit. Rev. Oncol. Hemat.</source>
<year>2006</year>
<volume>59</volume>
<fpage>159</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1016/j.critrevonc.2006.01.001</pub-id>
<?supplied-pmid 16806962?><pub-id pub-id-type="pmid">16806962</pub-id></element-citation></ref><ref id="B98-molecules-21-01252"><label>98.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Waseem</surname><given-names>M.</given-names></name><name><surname>Parvez</surname><given-names>S.</given-names></name></person-group>
<article-title>Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin</article-title>
<source>Protoplasma</source>
<year>2016</year>
<volume>253</volume>
<fpage>417</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="doi">10.1007/s00709-015-0821-6</pub-id>
<?supplied-pmid 26022087?><pub-id pub-id-type="pmid">26022087</pub-id></element-citation></ref><ref id="B99-molecules-21-01252"><label>99.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morand</surname><given-names>C.</given-names></name><name><surname>Manach</surname><given-names>C.</given-names></name><name><surname>Crespy</surname><given-names>V.</given-names></name><name><surname>Remesy</surname><given-names>C.</given-names></name></person-group>
<article-title>Respective bioavailability of quercetin aglycone and its glycosides in a rat model</article-title>
<source>BioFactors</source>
<year>2000</year>
<volume>12</volume>
<fpage>169</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1002/biof.5520120127</pub-id>
<?supplied-pmid 11216481?><pub-id pub-id-type="pmid">11216481</pub-id></element-citation></ref><ref id="B100-molecules-21-01252"><label>100.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raygude</surname><given-names>K.S.</given-names></name><name><surname>Kandhare</surname><given-names>A.D.</given-names></name><name><surname>Ghosh</surname><given-names>P.</given-names></name><name><surname>Ghule</surname><given-names>A.E.</given-names></name><name><surname>Bodhankar</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats</article-title>
<source>Inflammopharmacology</source>
<year>2012</year>
<volume>20</volume>
<fpage>331</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1007/s10787-012-0122-z</pub-id>
<?supplied-pmid 22349996?><pub-id pub-id-type="pmid">22349996</pub-id></element-citation></ref><ref id="B101-molecules-21-01252"><label>101.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>P.A.</given-names></name><name><surname>Braune</surname><given-names>A.</given-names></name><name><surname>Haller</surname><given-names>D.R.</given-names></name></person-group>
<article-title>Quercetin inhibits tnf-induced irf-1 but not nf-kappa b recruitment to the ip-10 gene promoter in intestinal epithelial cells through the modulation of histone acetyl transferase activity</article-title>
<source>Gastroenterology</source>
<year>2006</year>
<volume>130</volume>
<fpage>A693</fpage>
<lpage>A693</lpage>
</element-citation></ref><ref id="B102-molecules-21-01252"><label>102.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ferry</surname><given-names>D.R.</given-names></name><name><surname>Smith</surname><given-names>A.</given-names></name><name><surname>Malkhandi</surname><given-names>J.</given-names></name><name><surname>Fyfe</surname><given-names>D.W.</given-names></name><name><surname>DeTakats</surname><given-names>P.G.</given-names></name><name><surname>Anderson</surname><given-names>D.</given-names></name><name><surname>Baker</surname><given-names>J.</given-names></name><name><surname>Kerr</surname><given-names>D.J.</given-names></name></person-group>
<article-title>Phase i clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition</article-title>
<source>Clin. Cancer Res.</source>
<year>1996</year>
<volume>2</volume>
<fpage>659</fpage>
<lpage>668</lpage>
<?supplied-pmid 9816216?><pub-id pub-id-type="pmid">9816216</pub-id></element-citation></ref><ref id="B103-molecules-21-01252"><label>103.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zaveri</surname><given-names>N.T.</given-names></name></person-group>
<article-title>Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications</article-title>
<source>Life Sci.</source>
<year>2006</year>
<volume>78</volume>
<fpage>2073</fpage>
<lpage>2080</lpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2005.12.006</pub-id>
<?supplied-pmid 16445946?><pub-id pub-id-type="pmid">16445946</pub-id></element-citation></ref><ref id="B104-molecules-21-01252"><label>104.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khan</surname><given-names>N.</given-names></name><name><surname>Mukhtar</surname><given-names>H.</given-names></name></person-group>
<article-title>Cancer and metastasis: Prevention and treatment by green tea</article-title>
<source>Cancer Metast. Rev.</source>
<year>2010</year>
<volume>29</volume>
<fpage>435</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1007/s10555-010-9236-1</pub-id>
<?supplied-pmid 20714789?><pub-id pub-id-type="pmid">20714789</pub-id></element-citation></ref><ref id="B105-molecules-21-01252"><label>105.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakachi</surname><given-names>K.</given-names></name><name><surname>Suemasu</surname><given-names>K.</given-names></name><name><surname>Suga</surname><given-names>K.</given-names></name><name><surname>Takeo</surname><given-names>T.</given-names></name><name><surname>Imai</surname><given-names>K.</given-names></name><name><surname>Higashi</surname><given-names>Y.</given-names></name></person-group>
<article-title>Influence of drinking green tea on breast cancer malignancy among japanese patients</article-title>
<source>Jpn. J. Cancer Res.</source>
<year>1998</year>
<volume>89</volume>
<fpage>254</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1111/j.1349-7006.1998.tb00556.x</pub-id>
<?supplied-pmid 9600118?><pub-id pub-id-type="pmid">9600118</pub-id></element-citation></ref><ref id="B106-molecules-21-01252"><label>106.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saville</surname><given-names>M.W.</given-names></name><name><surname>Lietzau</surname><given-names>J.</given-names></name><name><surname>Pluda</surname><given-names>J.M.</given-names></name><name><surname>Feuerstein</surname><given-names>I.</given-names></name><name><surname>Odom</surname><given-names>J.</given-names></name><name><surname>Wilson</surname><given-names>W.H.</given-names></name><name><surname>Humphrey</surname><given-names>R.W.</given-names></name><name><surname>Feigal</surname><given-names>E.</given-names></name><name><surname>Steinberg</surname><given-names>S.M.</given-names></name><name><surname>Broder</surname><given-names>S.</given-names></name><etal/></person-group>
<article-title>Treatment of hiv-associated kaposi&#x02019;s sarcoma with paclitaxel</article-title>
<source>Lancet</source>
<year>1995</year>
<volume>346</volume>
<fpage>26</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(95)92654-2</pub-id>
<pub-id pub-id-type="pmid">7603142</pub-id></element-citation></ref><ref id="B107-molecules-21-01252"><label>107.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bharadwaj</surname><given-names>R.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name></person-group>
<article-title>The spindle checkpoint, aneuploidy, and cancer</article-title>
<source>Oncogene</source>
<year>2004</year>
<volume>23</volume>
<fpage>2016</fpage>
<lpage>2027</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1207374</pub-id>
<?supplied-pmid 15021889?><pub-id pub-id-type="pmid">15021889</pub-id></element-citation></ref><ref id="B108-molecules-21-01252"><label>108.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grisold</surname><given-names>W.</given-names></name><name><surname>Cavaletti</surname><given-names>G.</given-names></name><name><surname>Windebank</surname><given-names>A.J.</given-names></name></person-group>
<article-title>Peripheral neuropathies from chemotherapeutics and targeted agents: Diagnosis, treatment, and prevention</article-title>
<source>Neuro-Oncology</source>
<year>2012</year>
<volume>14</volume>
<fpage>45</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1093/neuonc/nos203</pub-id>
<?supplied-pmid 23095830?><pub-id pub-id-type="pmid">23095830</pub-id></element-citation></ref><ref id="B109-molecules-21-01252"><label>109.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Campos</surname><given-names>A.C.</given-names></name><name><surname>Moreira</surname><given-names>F.A.</given-names></name><name><surname>Gomes</surname><given-names>F.V.</given-names></name><name><surname>del Bel</surname><given-names>E.A.</given-names></name><name><surname>Guimaraes</surname><given-names>F.S.</given-names></name></person-group>
<article-title>Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders</article-title>
<source>Philos. Trans. R. Soc. B</source>
<year>2012</year>
<volume>367</volume>
<fpage>3364</fpage>
<lpage>3378</lpage>
<pub-id pub-id-type="doi">10.1098/rstb.2011.0389</pub-id>
<?supplied-pmid 23108553?><pub-id pub-id-type="pmid">23108553</pub-id></element-citation></ref><ref id="B110-molecules-21-01252"><label>110.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mechoulam</surname><given-names>R.</given-names></name><name><surname>Parker</surname><given-names>L.A.</given-names></name><name><surname>Gallily</surname><given-names>R.</given-names></name></person-group>
<article-title>Cannabidiol: An overview of some pharmacological aspects</article-title>
<source>J. Clin. Pharmacol.</source>
<year>2002</year>
<volume>42</volume>
<issue>Suppl. 1</issue>
<fpage>11S</fpage>
<lpage>19S</lpage>
<pub-id pub-id-type="doi">10.1002/j.1552-4604.2002.tb05998.x</pub-id>
<?supplied-pmid 12412831?><pub-id pub-id-type="pmid">12412831</pub-id></element-citation></ref><ref id="B111-molecules-21-01252"><label>111.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andoh</surname><given-names>T.</given-names></name><name><surname>Kitamura</surname><given-names>R.</given-names></name><name><surname>Fushimi</surname><given-names>H.</given-names></name><name><surname>Komatsu</surname><given-names>K.</given-names></name><name><surname>Shibahara</surname><given-names>N.</given-names></name><name><surname>Kuraishi</surname><given-names>Y.</given-names></name></person-group>
<article-title>Effects of goshajinkigan, hachimijiogan, and rokumigan on mechanical allodynia induced by paclitaxel in mice</article-title>
<source>J. Tradit. Complement. Med.</source>
<year>2014</year>
<volume>4</volume>
<fpage>293</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.4103/2225-4110.128906</pub-id>
<?supplied-pmid 25379475?><pub-id pub-id-type="pmid">25379475</pub-id></element-citation></ref><ref id="B112-molecules-21-01252"><label>112.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Materazzi</surname><given-names>S.</given-names></name><name><surname>Fusi</surname><given-names>C.</given-names></name><name><surname>Benemei</surname><given-names>S.</given-names></name><name><surname>Pedretti</surname><given-names>P.</given-names></name><name><surname>Patacchini</surname><given-names>R.</given-names></name><name><surname>Nilius</surname><given-names>B.</given-names></name><name><surname>Prenen</surname><given-names>J.</given-names></name><name><surname>Creminon</surname><given-names>C.</given-names></name><name><surname>Geppetti</surname><given-names>P.</given-names></name><name><surname>Nassini</surname><given-names>R.</given-names></name></person-group>
<article-title>Trpa1 and trpv4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism</article-title>
<source>Pflugers Arch. Eur. J. Physiol.</source>
<year>2012</year>
<volume>463</volume>
<fpage>561</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1007/s00424-011-1071-x</pub-id>
<?supplied-pmid 22258694?><pub-id pub-id-type="pmid">22258694</pub-id></element-citation></ref><ref id="B113-molecules-21-01252"><label>113.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alessandri-Haber</surname><given-names>N.</given-names></name><name><surname>Dina</surname><given-names>O.A.</given-names></name><name><surname>Joseph</surname><given-names>E.K.</given-names></name><name><surname>Reichling</surname><given-names>D.B.</given-names></name><name><surname>Levine</surname><given-names>J.D.</given-names></name></person-group>
<article-title>Interaction of transient receptor potential vanilloid 4, integrin, and src tyrosine kinase in mechanical hyperalgesia</article-title>
<source>J. Neurosci.</source>
<year>2008</year>
<volume>28</volume>
<fpage>1046</fpage>
<lpage>1057</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4497-07.2008</pub-id>
<?supplied-pmid 18234883?><pub-id pub-id-type="pmid">18234883</pub-id></element-citation></ref><ref id="B114-molecules-21-01252"><label>114.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goswami</surname><given-names>C.</given-names></name></person-group>
<article-title>Trpv1-tubulin complex: Involvement of membrane tubulin in the regulation of chemotherapy-induced peripheral neuropathy</article-title>
<source>J. Neurochem.</source>
<year>2012</year>
<volume>123</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07892.x</pub-id>
<?supplied-pmid 22845740?><pub-id pub-id-type="pmid">22845740</pub-id></element-citation></ref><ref id="B115-molecules-21-01252"><label>115.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gauchan</surname><given-names>P.</given-names></name><name><surname>Andoh</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>A.</given-names></name><name><surname>Kuraishi</surname><given-names>Y.</given-names></name></person-group>
<article-title>Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice</article-title>
<source>Neurosci. Lett.</source>
<year>2009</year>
<volume>458</volume>
<fpage>93</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2009.04.029</pub-id>
<?supplied-pmid 19375484?><pub-id pub-id-type="pmid">19375484</pub-id></element-citation></ref><ref id="B116-molecules-21-01252"><label>116.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>K.</given-names></name><name><surname>Kono</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Miyagi</surname><given-names>C.</given-names></name><name><surname>Omiya</surname><given-names>Y.</given-names></name><name><surname>Miyano</surname><given-names>K.</given-names></name><name><surname>Kase</surname><given-names>Y.</given-names></name><name><surname>Uezono</surname><given-names>Y.</given-names></name></person-group>
<article-title>Goshajinkigan, a traditional japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of trp channels in rat</article-title>
<source>J. Pharmacol. Sci.</source>
<year>2014</year>
<volume>125</volume>
<fpage>91</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1254/jphs.13244FP</pub-id>
<?supplied-pmid 24784702?><pub-id pub-id-type="pmid">24784702</pub-id></element-citation></ref><ref id="B117-molecules-21-01252"><label>117.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumura</surname><given-names>Y.</given-names></name><name><surname>Yokoyama</surname><given-names>Y.</given-names></name><name><surname>Hirakawa</surname><given-names>H.</given-names></name><name><surname>Shigeto</surname><given-names>T.</given-names></name><name><surname>Futagami</surname><given-names>M.</given-names></name><name><surname>Mizunuma</surname><given-names>H.</given-names></name></person-group>
<article-title>The prophylactic effects of a traditional japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action</article-title>
<source>Mol. Pain</source>
<year>2014</year>
<volume>10</volume>
<fpage>61</fpage>
<pub-id pub-id-type="doi">10.1186/1744-8069-10-61</pub-id>
<?supplied-pmid 25240613?><pub-id pub-id-type="pmid">25240613</pub-id></element-citation></ref><ref id="B118-molecules-21-01252"><label>118.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bifulco</surname><given-names>M.</given-names></name><name><surname>Malfitano</surname><given-names>A.M.</given-names></name><name><surname>Pisanti</surname><given-names>S.</given-names></name><name><surname>Laezza</surname><given-names>C.</given-names></name></person-group>
<article-title>Endocannabinoids in endocrine and related tumours</article-title>
<source>Endocr. Relat. Cancer</source>
<year>2008</year>
<volume>15</volume>
<fpage>391</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1677/ERC-07-0258</pub-id>
<?supplied-pmid 18508995?><pub-id pub-id-type="pmid">18508995</pub-id></element-citation></ref><ref id="B119-molecules-21-01252"><label>119.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McKallip</surname><given-names>R.J.</given-names></name><name><surname>Lombard</surname><given-names>C.</given-names></name><name><surname>Fisher</surname><given-names>M.</given-names></name><name><surname>Martin</surname><given-names>B.R.</given-names></name><name><surname>Ryu</surname><given-names>S.H.</given-names></name><name><surname>Grant</surname><given-names>S.</given-names></name><name><surname>Nagarkatti</surname><given-names>P.S.</given-names></name><name><surname>Nagarkatti</surname><given-names>M.</given-names></name></person-group>
<article-title>Targeting cb2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease</article-title>
<source>Blood</source>
<year>2002</year>
<volume>100</volume>
<fpage>627</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2002-01-0098</pub-id>
<?supplied-pmid 12091357?><pub-id pub-id-type="pmid">12091357</pub-id></element-citation></ref><ref id="B120-molecules-21-01252"><label>120.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Bekele</surname><given-names>B.N.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name><name><surname>Caraway</surname><given-names>N.P.</given-names></name><name><surname>Katz</surname><given-names>R.L.</given-names></name><name><surname>Stass</surname><given-names>S.A.</given-names></name><name><surname>Jiang</surname><given-names>F.</given-names></name></person-group>
<article-title>Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach</article-title>
<source>Oncogene</source>
<year>2006</year>
<volume>25</volume>
<fpage>2628</fpage>
<lpage>2635</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1209289</pub-id>
<?supplied-pmid 16369491?><pub-id pub-id-type="pmid">16369491</pub-id></element-citation></ref><ref id="B121-molecules-21-01252"><label>121.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramer</surname><given-names>R.</given-names></name><name><surname>Rohde</surname><given-names>A.</given-names></name><name><surname>Merkord</surname><given-names>J.</given-names></name><name><surname>Rohde</surname><given-names>H.</given-names></name><name><surname>Hinz</surname><given-names>B.</given-names></name></person-group>
<article-title>Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells</article-title>
<source>Pharm. Res.</source>
<year>2010</year>
<volume>27</volume>
<fpage>2162</fpage>
<lpage>2174</lpage>
<pub-id pub-id-type="doi">10.1007/s11095-010-0219-2</pub-id>
<?supplied-pmid 20668920?><pub-id pub-id-type="pmid">20668920</pub-id></element-citation></ref><ref id="B122-molecules-21-01252"><label>122.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.M.</given-names></name><name><surname>Lehky</surname><given-names>T.J.</given-names></name><name><surname>Brell</surname><given-names>J.M.</given-names></name><name><surname>Dorsey</surname><given-names>S.G.</given-names></name></person-group>
<article-title>Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy</article-title>
<source>Cytokine</source>
<year>2012</year>
<volume>59</volume>
<fpage>3</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.cyto.2012.03.027</pub-id>
<?supplied-pmid 22537849?><pub-id pub-id-type="pmid">22537849</pub-id></element-citation></ref><ref id="B123-molecules-21-01252"><label>123.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiurchiu</surname><given-names>V.</given-names></name><name><surname>Leuti</surname><given-names>A.</given-names></name><name><surname>Maccarrone</surname><given-names>M.</given-names></name></person-group>
<article-title>Cannabinoid signaling and neuroinflammatory diseases: A melting pot for the regulation of brain immune responses</article-title>
<source>J. Neuroimmune Pharmacol.</source>
<year>2015</year>
<volume>10</volume>
<fpage>268</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1007/s11481-015-9584-2</pub-id>
<?supplied-pmid 25601726?><pub-id pub-id-type="pmid">25601726</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="molecules-21-01252-t001" position="float"><object-id pub-id-type="pii">molecules-21-01252-t001_Table 1</object-id><label>Table 1</label><caption><p>Phytochemicals against CIPN.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phytochemical</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemotherapy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Refs.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Auraptenol <break/><inline-graphic xlink:href="molecules-21-01252-i001.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.05&#x02013;0.8 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vincristine in mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses mechanical hyperalgesia and alteration of behavioral and biochemical changes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-molecules-21-01252" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cannabidiol <break/><inline-graphic xlink:href="molecules-21-01252-i002.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5&#x02013;10 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paclitaxel in mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits neuropathic pain through 5-HT<sub>1A</sub> receptor signaling without diminishing chemothferapy efficacy or nervous system function </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-molecules-21-01252" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin <break/><inline-graphic xlink:href="molecules-21-01252-i003.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cisplatin or oxaliplatin in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverses the alterations of neurotensin levels in the plasma, protects the sciatic nerve from injury, and reduces drug absorption in the sciatic nerve</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B24-molecules-21-01252" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rutin <break/><inline-graphic xlink:href="molecules-21-01252-i004.jpg"/>
<break/>&#x00026; quercetin <break/><inline-graphic xlink:href="molecules-21-01252-i005.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25&#x02013;100 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxaliplatin in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">prevent the shrinkage of neurons and inhibit edema</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-molecules-21-01252" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Verticinone <break/><inline-graphic xlink:href="molecules-21-01252-i006.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5&#x02013;3 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paclitaxel in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Has a relatively constant analgesic effect; the analgesic effect of morphine was decreased after repeated medication</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B26-molecules-21-01252" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xylopic acid <break/><inline-graphic xlink:href="molecules-21-01252-i007.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10&#x02013;100 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vincristine in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Has anti-allodynic and anti-hyperalgesic properties</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-molecules-21-01252" ref-type="bibr">27</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="molecules-21-01252-t002" position="float"><object-id pub-id-type="pii">molecules-21-01252-t002_Table 2</object-id><label>Table 2</label><caption><p>Medicinal herbs against CIPN.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Herbs</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Dose</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Chemotherapy</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Effects</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Refs.</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acorus calamus</italic></td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">100&#x02013;200 mg/kg</td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vincristine in rats</td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Attenuates symptoms of neuropathy through serotonin 5-HT<sub>1A</sub> receptors</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B28-molecules-21-01252" ref-type="bibr">28</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Butea monosperma</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">200&#x02013;400 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vincristine in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverses alterations of behavioral, biochemical, and histopathological changes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-molecules-21-01252" ref-type="bibr">29</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Ginkgo biloba</italic> L. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50&#x02013;150 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vincristine in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreases paw-withdrawal frequency to cold stimuli and increases the threshold to mechanical stimuli <break/>Suppresses NF-&#x003ba;B activation and production of TNF-&#x003b1; and NO <break/>Inhibits axonal degradation <break/>Improves axonal transportation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-molecules-21-01252" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100&#x02013;200 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cisplatin in rats, mice, guinea pigs</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protects the inner ear from ototoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B31-molecules-21-01252" ref-type="bibr">31</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Camellia sinensis</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxaliplatin in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alleviates mechanical allodynia and thermal hyperalgesia, but does not prevent morphometric or electrophysiological alterations</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-molecules-21-01252" ref-type="bibr">32</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ocimum sanctum</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100&#x02013;200 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vincristine in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Attenuates neurotoxicity with the decline in calcium levels and oxidative stress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B33-molecules-21-01252" ref-type="bibr">33</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Salvia officinalis</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cisplatin in mice,</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses a second phase of cisplatin-enhanced pain in the formalin test</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B34-molecules-21-01252" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Walnut</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6% of diet</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cisplatin in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits an alteration in performance of hippocampus- and cerebellum-related behaviors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B35-molecules-21-01252" ref-type="bibr">35</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Xylopia aethiopica</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30&#x02013;300 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vincristine in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Has anti-allodynic and anti-hyperalgesic properties</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-molecules-21-01252" ref-type="bibr">27</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="molecules-21-01252-t003" position="float"><object-id pub-id-type="pii">molecules-21-01252-t003_Table 3</object-id><label>Table 3</label><caption><p>Herbal formulas against CIPN.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Herbal Formula</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Herbs Composition</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Chemotherapy</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Effects</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Refs.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gyejigachulbu-Tang</td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aconiti tuber</italic>, <italic>Atractylodis lanceae rhizome</italic>, <italic>Cinnamomi cortex</italic>, <italic>Glycyrrhizae radix</italic>, <italic>Paeoniae radix</italic>, <italic>Zingiberis rhizoma</italic>, <italic>Zizyphi fructus</italic></td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Oxaliplatin in rats</td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Attenuates cold and mechanical allodynia <break/>Suppresses spinal glia activation</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B36-molecules-21-01252" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gyeryongtongrac-Bang</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ramulus cinnamomi</italic>, <italic>Earthworm</italic>, <italic>Radix astragali,</italic>
<italic>Safflower</italic>, <italic>Radix angelicae sinensis, Ligusticum</italic>, <italic>Spatholobus</italic>, <italic>Radix paeoniae alba</italic>, <italic>Rhizoma curcumae</italic>, <italic>Licorice</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxaliplatin in a randomized, double-blind, placebo-controlled trial</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevents sensory neurotoxicity and delays its onset</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-molecules-21-01252" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hwanggiomul-Tang</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Zingiberis hizome, Jujubae fructus, Paeonia alba radix, Cinnamomi cortex,</italic>
<italic>Astragalus membranaceus radix</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A case study of oxaliplatin-treated 59-year-old man with recurrent colon cancer</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevents chronic cumulative neurotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-molecules-21-01252" ref-type="bibr">38</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Jakyakgamcho-Tang</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Paeoniae radix</italic><italic>, Glycyrrhizae radix</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paclitaxel in mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Relieves allodynia and a hyperalgesia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B39-molecules-21-01252" ref-type="bibr">39</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A retrospective case analysis investigated 23 patients with ovarian cancer treated with paclitaxel and carboplatin combination chemotherapy</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces pain in epithelial ovarian carcinoma </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B40-molecules-21-01252" ref-type="bibr">40</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Jesengsingi-Hwan</td><td rowspan="5" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Achyranthis bidentatae radix, Alismatis rhizome, Aconiti tuber, Cinnamomi cortex, Corni fructus, Dioscorea opposita rhizoma, Plantaginis semen, Poria alba, Moutan cortex, Rehmannia viride radix</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxaliplatin in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces peripheral neuropathy without influence on anti-cancer potency <break/>Ameliorates abnormal sensations and histological damage to the sciatic nerve</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-molecules-21-01252" ref-type="bibr">41</xref>,<xref rid="B42-molecules-21-01252" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paclitaxel in mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits mechanical allodynia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B43-molecules-21-01252" ref-type="bibr">43</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Oxaliplatin in a placebo-controlled double-blind randomized study</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Delays onset of grade 2 or greater peripheral neurotoxicity without impairing FOLFOX efficacy with an acceptable safety margin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B44-molecules-21-01252" ref-type="bibr">44</xref>,<xref rid="B45-molecules-21-01252" ref-type="bibr">45</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevents exacerbation of peripheral neuropathy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B46-molecules-21-01252" ref-type="bibr">46</xref>,<xref rid="B47-molecules-21-01252" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A clinical trial enrolling 82 patients</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces peripheral neuropathy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-molecules-21-01252" ref-type="bibr">48</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>